clopidogrel and Coronary Thrombosis

clopidogrel has been researched along with Coronary Thrombosis in 455 studies

Research

Studies (455)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	16 (3.52)	18.2507
2000's	198 (43.52)	29.6817
2010's	225 (49.45)	24.3611
2020's	16 (3.52)	2.80

Authors

Authors	Studies
Chu, Y; Ma, Q; Wang, C; Wang, H; Xu, Y; Yu, X	1
Asselbergs, FW; Barbato, E; Bergmeijer, TO; Boersma, C; Claassens, DMF; de Boer, A; Deneer, VHM; Dewilde, WJM; Hermanides, RS; Herrman, JR; Janssen, PWA; Kelder, JC; Morisco, C; Mosterd, A; Postma, MJ; Ten Berg, JM; Tjon Joe Gin, RM; van 't Hof, AWJ; van der Harst, P; Vos, GJA	1
Alexopoulos, D; Altman, RB; Aradi, D; Backman, JD; Bergmeijer, TO; Bliden, KP; Campo, G; Chang, K; Cleator, JH; Déry, JP; Dridi, NP; Fernandez-Cadenas, I; Fontana, P; Gawaz, M; Geisler, T; Gensini, GF; Giusti, B; Gong, L; Gurbel, PA; Hochholzer, W; Holmvang, L; Kim, EY; Kim, HS; Klein, TE; Kubo, M; Lee, MTM; Lewis, JP; Marcucci, R; Mitchell, BD; Montaner, J; Pakyz, RE; Reny, JL; Ritchie, MD; Roden, DM; Ryan, K; Schaeffeler, E; Schwab, M; Shin, JG; Shuldiner, AR; Siller-Matula, JM; Ten Berg, JM; Trenk, D; Valgimigli, M; Wen, MS; Whaley, RM; Winter, S	1
Jiang, J; Li, C; Shen, X; Sun, Y; Tao, M; Wang, DW; Wang, Y; Yan, J; Ye, H; Yu, B; Yu, T; Zeng, H; Zhang, L	1
Foerch, C; Lieschke, F; Schaefer, JH; van Leyen, K; Wang, X; Zheng, Y	1
Akita, K; Amano, T; Inohara, T; Ishii, H; Kadota, K; Kohsaka, S; Maekawa, Y; Nakamura, M; Numasawa, Y; Yamaji, K	1
Ceriello, A; Di Sciascio, G; Grigioni, F; Manfrini, S; Melfi, R; Nicolucci, A; Nusca, A; Pozzilli, P; Proscia, C; Tuccinardi, D; Ussia, GP	1
Ali, ZA; Baber, U; Ben-Yehuda, O; Brodie, BR; Chen, S; Cox, DA; Duffy, PL; Henry, TD; Kirtane, AJ; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Redfors, B; Rinaldi, MJ; Rubin, GA; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Zhang, Y	1
Barbato, E; Bressi, E; Capuano, M; Cavallari, I; Colaiori, I; Di Sciascio, G; Mangiacapra, F; Ricottini, E; Spoto, S; Viscusi, MM	1
Ayari, A; Barra, N; Billé, J; Joly, P; Maillard, L; Peycher, P; Sévilla, J; Silvestri, M; Tavildari, A; Vochelet, F	1
Angiolillo, DJ; Bergmeijer, TO; Capodanno, D; Danchin, N; Price, MJ; Sibbing, D; Simon, T; Ten Berg, JM	1
Belle, L; Berthier, R; Cayla, G; Chevalier, B; Funck, F; Hulot, JS; Khalife, K; Montalescot, G; Piot, C; Tafflet, M	1
Bergmeijer, TO; Claassens, DMF; Deneer, VHM; Hermanides, RS; Hinrichs, DL; Tavenier, AH; Ten Berg, JM; van 't Hof, AWJ; Vos, GJA	1
Chai, M; Liang, J; Liu, W; Liu, X; Xi, Z; Yu, Y; Zhao, Y; Zhou, Y	1
Al Faraidy, KA; Al-Ali, AK; Al-Mansori, MA; Al-Muhanna, FA; Al-Rubaish, AM; Alali, RA; Alshehri, AM; Asselbergs, FW; Claassens, DMF; Cyrus, C; Khalil, RM; Sulieman, MM; Ten Berg, JM; Vatte, C	1
Aradi, D; Baquet, M; Gschwendtner, S; Hochholzer, W; Hoffmann, E; Jochheim, D; Kastrati, A; Mansmann, U; Massberg, S; Mayer, K; Mehilli, J; Neumann, FJ; Schüpke, S; Sibbing, D; Tesche, C; Thienel, M; Xu, Y; Zadrozny, M	1
Chen, R; Li, J; Liu, C; Sheng, Z; Song, L; Tan, Y; Yan, H; Zhao, H; Zhou, J; Zhou, P	1
Abe, M; Ando, K; Igarashi Hanaoka, K; Ikari, Y; Kadota, K; Kawai, K; Kimura, T; Kozuma, K; Morimoto, T; Morino, Y; Nakao, K; Natsuaki, M; Tanabe, K; Watanabe, H	1
Asada, K; Fukuyama, M; Hira, D; Horie, M; Isono, T; Miyamoto, A; Nakagawa, Y; Ozawa, T; Sakai, H; Sawayama, Y; Terada, T; Tomita, Y; Yagi, N; Yamamoto, T	1
Apruzzese, PK; Cutlip, DE; Kereiakes, DJ; Massaro, JM; Mauri, L; Secemsky, EA; Steg, PG; Yeh, RW	1
Boersma, E; Diletti, R; Fam, JM; Felix, CM; IJsselmuiden, AJJ; Lansink, WJ; Onuma, Y; Regar, ES; Smits, PC; van Geuns, RJM; Vlachojannis, GJ; Zijlstra, F	1
Huang, C; Wang, Y; Wu, Y; Xu, W; Yan, H; Zhang, L; Zhou, Y; Zhu, J; Zhu, W	1
Armengaud, J; Barragan, P; Ben Amer, H; Berlan, J; Blanchard, D; Bressolette, E; Carrie, D; Cassat, C; Castellant, P; Cazaux, P; Champagnac, D; Darremont, O; Dauphin, R; Delarche, N; Didier, R; Druelles, P; Dupouy, P; Furber, A; Gilard, M; Gommeaux, A; Hovasse, T; Jouve, B; Kermarrec, A; Kiss, RG; Le Breton, H; Levy, G; Lyuycx-Bore, A; Maillard, L; Majwal, T; Morice, MC; Noor, HA; Noryani, AAL; Ohlmann, P; Ormezzano, O; Paganelli, F; Sainsous, J; Schneeberger, M; Ungi, I; Wojcik, J	1
Jiang, M; You, JHS	1
Aquino, M; Baber, U; Baker, BA; Chandrasekhar, J; Dangas, G; DeFranco, A; Effron, MB; Faggioni, M; Farhan, S; Henry, TD; Kapadia, S; Keller, S; Kini, AS; Mehran, R; Muhlestein, JB; Pocock, S; Rao, S; Sartori, S; Strauss, C; Toma, C; Vogel, B; Weintraub, W; Weiss, S	1
Ben-Yehuda, O; Brodie, BR; Cox, DA; Duffy, PL; Généreux, P; Gurbel, PA; Henry, TD; Kirtane, AJ; Litherland, C; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Rinaldi, MJ; Simonton, CA; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B	1
Adriaenssens, T; Bernlochner, I; Byrne, RA; Colleran, R; Emmer, R; Fischer, M; Giacoppo, D; Han, Y; Harada, Y; Ibrahim, T; Jacobshagen, C; Kastrati, A; Kufner, S; Lahmann, AL; Laugwitz, KL; Lohaus, R; Maeng, M; Mayer, K; Mehilli, J; Michel, J; Morath, T; Neumann, FJ; Schulz-Schüpke, S; Schunkert, H; Seyfarth, M; Ten Berg, JM; Tölg, R; Wöhrle, J; Wolk, A; Zrenner, B	1
Baber, U; Badimon, JJ; Contreras, J; Escolar, G; Fuster, V; Linares-Koloffon, CA; Mehran, R; Rey-Mendoza, J; Sartori, S; Smith, DA; Zafar, MU	1
Abizaid, A; Bhatt, DL; Colombo, A; Feres, F; Gilard, M; Hong, MK; Kim, HS; Morice, MC; Palmerini, T; Piccolo, R; Stone, GW; Valgimigli, M; Windecker, S	1
Bossard, M; Faxon, DP; Fox, KAA; Gao, P; Granger, CB; Jolly, SS; Mehta, SR; Montalescot, G; Natarajan, MK; Niemela, K; Steg, PG; Tanguay, JF; Widimsky, P; Yusuf, S	1
Cooper, R; Curzen, N; Kemp, I; Khanna, V; Mars, C; Shahzad, A; Shaw, M; Stables, RH; Wilson, K	1
Aquino, M; Baber, U; Baker, BA; Chandrasekhar, J; Dangas, G; DeFranco, A; Effron, MB; Farhan, S; Ge, Z; Henry, TD; Kapadia, S; Keller, S; Kini, AS; Mehran, R; Muhlestein, JB; Pocock, S; Rao, S; Sartori, S; Sorrentino, S; Strauss, C; Toma, C; Vogel, B; Weintraub, W; Weiss, S	1
Alexopoulos, D; Bona, RD; Bongo, AS; Capodanno, D; Gaudio, G; Guasti, L; Lupi, A; Meliga, E; Porto, I; Schaffer, A; Valgimigli, M	1
Bundhun, PK; Huang, F	1
Amin, AP; Bhatt, DL; Fan, W; Généreux, P; Gibson, CM; Harrington, RA; Kirtane, AJ; Pinto, DS; Stone, GW; Tamez, H; White, HD; Yeh, RW	1
Alves, RC; Cantarelli, FL; de Barros, IML; de Oliveira, FRA; Falcão, FJA; Nascimento Silva, JS; Pedrosa, RP; Silva, JMDS	1
Bortone, AS; Cecere, A; Ciccone, MM; D'Alessandro, P; Favale, S; Fumarola, F; Giordano, A; Guaricci, AI; Marchese, A; Pepe, M	1
Alfredsson, J; Erlinge, D; James, S; Jernberg, T; Omerovic, E; Persson, J; Ravn-Fischer, A; Svennblad, B; Tornvall, P; Ueda, P; Varenhorst, C	1
Fan, CJ; Hu, HY; Li, XY; Su, GH; Wang, GX	1
Endo, T; Hanada, K; Higuma, T; Nishizaki, F; Okumura, K; Tomita, H; Yamada, M; Yokota, T; Yokoyama, H	1
Brener, SJ; Brodie, BR; Cox, DA; Duffy, PL; Gurbel, PA; Henry, TD; Kirtane, AJ; Mazzaferri, EL; McAndrew, T; Mehran, R; Metzger, DC; Neumann, FJ; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B	1
Castelli, P; Cosentino, M; Ferrari, M; Marino, F; Mirabile, M; Riva, F; Tarallo, A; Tozzi, M	1
Banerjee, S; Baskar, A; Chauhan, S; Cui, Z; Dargham, BB; Sum-Ping, J; Tejani, I; Weideman, RA	1
Baber, U; Chieffo, A; Cohen, DJ; Colombo, A; Dangas, G; Gibson, CM; Henry, TD; Kini, A; Krucoff, M; Leisman, DE; Mehran, R; Moliterno, D; Pocock, SJ; Sartori, S; Steg, PG; Witzenbichler, B	1
Åkerblom, A; Asselbergs, FW; Becker, RC; Bernlochner, I; Bopp, R; Byrne, RA; Erdmann, J; Eriksson, N; James, S; Kastrati, A; Katus, HA; Kessler, T; Koenig, W; Kofink, D; Laugwitz, KL; Mahmoodi, BK; Mayer, K; Munz, M; Nordio, F; O'Donoghue, ML; Rai, H; Sager, HB; Schunkert, H; Sibbing, D; Solakov, L; Storey, RF; Ten Berg, JM; Tragante, V; Wallentin, L; Wobst, J; Wolf, B	1
Abtan, J; Bhatt, DL; Deliargyris, EN; Ducrocq, G; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Akutsu, N; Fukamachi, D; Hirayama, A; Hiro, T; Kitano, D; Kojima, K; Migita, S; Mineki, T; Morikawa, T; Murata, N; Okumura, Y; Sudo, M; Takayama, T; Tamaki, T	1
Aberg, JA; Badimon, JJ; Cavanagh, K; Escolar, G; Heyison, A; O'Brien, MP; Okoroafor, I; Rodriguez, JC; Rodriguez-Caprio, G; Weinberg, A; Zafar, MU	1
Almalla, M; Hennings, V; Hoffmann, R; Marx, N; Schröder, J	1
Bagur, R; Barbeau, G; Bertrand, OF; De Larochellière, R; Déry, JP; Dorais, M; Gleeton, O; Larose, E; Nguyen, CM; Noël, B; Proulx, G; Rinfret, S; Rodés-Cabau, J; Roy, L; Taillon, I	1
Alfonso, F; Bañuelos, C; Echavarría-Pinto, M; Escaned, J; Fernández, C; Fernandez-Ortiz, A; García, E; Gonzalo, N; Gorgadze, T; Hernández, R; Ibañez, B; Jiménez-Quevedo, P; Lopes, R; Macaya, C; Nuñez-Gil, IJ	1
Janus, M; Lesiak, M; Lukawski, K; Prech, M	1
Storey, RF	1
Choi, D; Choi, HH; Her, AY; Hong, MK; Jang, Y; Kim, BK; Kim, JS; Kim, YH; Ko, YG; Park, J; Shin, DH	1
Berglund, U; Janzon, M; Nilsson, L	1
Cano, P; Conesa, P; Consuegra-Sánchez, L; Dau, D; Jaulent, L; Picó, F; Torres-Moreno, D; Villegas, M	1
Gurbel, PA; Tantry, US	2
Emanuelsson, H; Gibson, CM; Harrington, RA; Horrow, J; James, SK; Katus, H; Kunadian, V; Maya, J; Steg, PG; Storey, RF; Wallentin, L; Wojdyla, DM; Wu, J; Zorkun, C	1
Han, YL; Kang, J; Li, Y; Liang, ZY; Yan, CH; Zhang, XL	1
Emanuelsson, H; Harrington, RA; James, SK; Katus, HA; Lewis, BS; Mahaffey, KW; Maurer, G; Meier, B; Steg, PG; Storey, RF; Wallentin, L; Wojdyla, DM	1
Alessi, MC; Beguin, S; Bonnet, JL; Camoin, L; Cuisset, T; Grosdidier, C; Lambert, M; Loosveld, M; Loundou, AD; Morange, PE; Pankert, M; Quilici, J	1
Ahn, T; Choi, H; Choi, IS; Han, SH; Kang, WC; Lee, K; Moon, CI; Oh, PC; Shin, EK; Suh, SY	1
Cha, KS; Chae, IH; Hwang, KK; Jeon, HK; Jeong, MH; Kang, HJ; Kang, SH; Kim, HS; Kim, S; Koo, BK; Kwon, HM; Lee, SY; Moon, KW; Oh, JH; Park, BE; Park, JJ; Park, KW; Park, TH; Rhew, JY; Shin, ES; Yang, HM; Yoon, JH	1
Changzhi, L; Dan, H; Jian, C; Mao, L; Suihua, H; Wei, W; Wenyi, T	1
Chen, Y; Huang, X; Tang, Y; Xie, Y; Zhang, Y	1
Limbruno, U; Musumeci, G	1
Briguori, C; Condorelli, G; De Micco, F; Focaccio, A; Latronico, MV; Pagnotta, P; Papa, L; Roncarati, R; Visconti, G; Viviani Anselmi, C	1
Borghesi, M; Campo, G; Cangiano, E; Cavazza, C; Marchesini, J; Minarelli, M; Parrinello, G; Scalone, A; Tebaldi, M; Tumscitz, C; Valgimigli, M; Vranckx, P	1
Angiolillo, DJ; Ariza, A; Cequier, A; Ferreiro, JL; Gómez-Hospital, JA; Gómez-Lara, J; Gracida, M; Homs, S; Lorente, V; Marcano, AL; Rivera, K; Romaguera, R; Roura, G; Sánchez-Elvira, G; Sánchez-Salado, JC; Sosa, SG; Teruel, L	1
Alessi, MC; Bonnet, G; Bonnet, JL; Cuisset, T; Deharo, P; Morange, P; Pankert, M; Quilici, J; Verdier, V	1
Cannon, CP; Gibson, CM; Giugliano, RP; Morrow, DA; Sabatine, MS; Scirica, BM; Sloan, S; Waks, JW; Wiviott, SD	1
Albertsson, P; Dellborg, M; Hansson, EC; Jeppsson, A; Rexius, H	1
Belardi, JA; Brar, S; Kirtane, AJ; Liu, M; Rothman, M; Silber, S; Windecker, S	1
Al Kurdi, M; Boersma, E; Camenzind, E; Mauri, L; Ordoubadi, FF; Rademaker-Havinga, T; Steg, PG; Suttorp, MJ; Wijns, W	1
Sabouret, P; Taiel-Sartral, M	1
Gray, S; Keville, N; Murray, AM	1
Bernlochner, I; Braun, S; Hausleiter, J; Kastrati, A; Laugwitz, KL; Massberg, S; Mayer, K; Morath, T; Schulz, S; Schunkert, H; Sibbing, D	1
Boothroyd, DB; Dudley, RA; Garber, AM; Hlatky, MA; Kazi, DS; Mell, MW; Moshkevich, S; Owens, DK; Rhee, C; Shah, RU	1
Er Ching, M; Ho, HH; Ong, PJ; Ooi, YW	1
Albert, F; Barbou, F; Belle, L; Berthier, R; Beygui, F; Brunel, P; Cazaux, P; Chassaing, S; Claudel, JP; Collet, JP; De Poli, F; Decomis, MP; Delarche, N; Dupouy, P; Köning, R; Montalescot, G; Rangé, G; Richard, P; Teiger, E; Thuaire, C; Yayehd, K	1
Alexopoulos, D; Davlouros, P; Deftereos, S; Giannopoulos, G; Gkizas, V	1
Aboujaoude, R; Ayers, J; Hsi, DH; Mandell, R; Sanghvi, K	1
Han, H; Li, Y; Liang, J; Liu, W; Liu, Y; Shi, D; Wang, Z; Yang, L; Zhang, L; Zhao, Y; Zhou, Y	1
Barbato, E; Boland, J; Chenu, P; Claeys, MJ; Cuisset, T; Dens, J; Gach, O; Legrand, V; Magne, J; Martinez, C; Vrolix, M; Wijns, W	1
Agrawal, N; Parekh, P; Vasavada, A; Vinchurkar, M	1
Bøtker, HE; Chisholm, GE; Jensen, LO; Johansen, MB; Kaltoft, A; Kristensen, SD; Krusell, LR; Lassen, JF; Maeng, M; Schmidt, M; Sørensen, HT; Thayssen, P; Thim, T; Thuesen, L; Tilsted, HH	1
Bernlochner, I; Braun, S; Hadamitzky, M; Hausleiter, J; Hoppmann, P; Kastrati, A; Laugwitz, KL; Massberg, S; Mayer, K; Mehilli, J; Morath, T; Orban, M; Schulz, S; Schunkert, H; Sibbing, D; Tiroch, K	1
Badimon, L; Cubedo, J; Juan-Babot, O; Martin-Yuste, V; Padró, T; Peña, E; Ramaiola, I; Sabate, M	1
Gawaz, M; Huber, K; Kristensen, SD; Schrör, K; Siller-Matula, JM; Storey, RF; Trenk, D	1
Angiolillo, DJ; Barozzi, C; Bartorelli, A; Bianchi, R; Calabrò, P; Capodanno, D; Cattaneo, M; De Carlo, M; De Rosa, R; De Servi, S; Della Riva, D; Généreux, P; Maffeo, D; Mariani, A; Mariani, M; Palmerini, T; Palmieri, C; Piscione, F; Podda, G; Reggiani, LB; Stone, GW; Taglieri, N; Tomasi, L; Toso, A	1
Judkins, C; Thompson, AG; Thompson, PL	1
Anselmi, CV; Bacci, M; Mendolicchio, GL; Quagliuolo, V; Rota, LL; Roveda, M; Ruggeri, ZM; Zavalloni, D	1
Alber, H; Bonetti, PO; Eberli, F; Erne, P; Galatius, S; Jeger, RV; Kaiser, CA; Pedrazzini, G; Pfisterer, ME; Rickli, H; Sørensen, R; von Felten, S	1
Ako, J; Shimohama, T	1
Choi, JH; Choi, RK; Choi, SH; Choi, YJ; Gwon, HC; Hahn, JY; Jang, HJ; Kim, JS; Kim, TH; Lee, HJ; Lee, SH; Park, JS; Park, TK; Roh, YM; Shim, WH; Song, YB; Yang, JH; Yu, CW	1
Cutlip, DE; Dauerman, HL; Kereiakes, DJ; Mauri, L; Stoler, R	1
Bhatt, DL; Cortese, B; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Liu, T; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD; Wilensky, M	1
Bogaert, J; Doulaptsis, K; Nessler, J; Ntoumpanaki, M; Sadowski, M; Undas, A; Woznicka, O; Ząbczyk, M; Zalewski, J	1
Hamasaki, T; Ichikawa, M; Kijima, Y; Takei, Y	1
Heitmeier, S; Laux, V; Perzborn, E	1
Caixeta, A; Généreux, P; Hermiller, JB; Jones-McMeans, J; Kedhi, E; Krucoff, MW; Palmerini, T; Rutledge, DR; Serruys, PW; Simonton, CA; Stone, GW; Sudhir, K; Wang, J	1
Langialonga, T; Maggi, A; Martimucci, M; Mele, M; Villella, A; Villella, M	1
Al-Hawwas, M; Azzalini, L; L'Allier, PL	1
Cao, H; Wang, DG; Wei, YQ; Yang, H	1
Duraj, L; Fedor, M; Galajda, P; Kovář, F; Kubisz, P; Mokáň, M; Samoš, M; Stančiaková, L; Staško, J	1
Abbate, R; Antoniucci, D; Cantini, G; Comito, V; Gensini, GF; Marcucci, R; Marrani, M; Migliorini, A; Parodi, G; Valenti, R	1
Bhatt, DL; Blankenship, JC; Deliargyris, EN; Généreux, P; Gibson, CM; Gutierrez, JA; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Kim, YS; Lee, SR	1
Kesavamoorthy, B; Virmani, R; Yahagi, K	1
Al Meman, AA; Khalaf, H; Rasool, S	1
Bougouin, W; Cariou, A; Dumas, F; Gouffran, G; Jakamy, R; Joffre, J; Lamhaut, L; Rosencher, J; Varenne, O	1
Brodie, BR; Cox, DA; Duffy, PL; Généreux, P; Henry, TD; Kirtane, AJ; Maehara, A; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Parikh, PB; Parvataneni, R; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Xu, K	1
Jing, Q; Li, R; Liu, P; Liu, Y; Tang, X; Wang, Q; Zhang, P	1
Adamo, M; Ariotti, S; Costa, F; Crimi, G; Leonardi, S; Valgimigli, M	1
Ariti, C; Baber, U; Chieffo, A; Cohen, DJ; Colombo, A; Dangas, G; Gibson, CM; Giustino, G; Henry, TD; Kini, AS; Kirtane, AJ; Krucoff, MW; Litherland, C; Mehran, R; Moliterno, DJ; Pocock, S; Sartori, S; Steg, PG; Stone, GW; Weisz, G; Witzenbichler, B	1
Baber, U; Berger, PB; Currier, J; Dave, RH; Henry, TD; Mehran, R; Nayyar, P; Rafique, AM; Tobis, J; Wang, TY	1
Choi, D; Her, AY; Hong, MK; Hong, SJ; Jang, Y; Kim, BK; Kim, JS; Kim, YH; Ko, YG; Shin, DH	1
Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; Vaduganathan, M; White, HD	1
Brener, SJ; Brodie, BR; Cox, DA; Duffy, PL; Henry, TD; Kirtane, AJ; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Parvataneni, R; Rinaldi, MJ; Stone, GW; Stuckey, TD; Witzenbichler, B	1
Abbosh, PH; Chen, DY; Derweesh, IH; Ginzburg, S; Greenberg, RE; Hamilton, Z; Ito, T; Kutikov, A; Mirheydar, H; Raheem, OA; Smaldone, MC; Uzzo, RG; Viterbo, R	1
Broderick, TM; Dalia, AA; Essandoh, MK; Flores, AS; George, BS; Kirtane, AJ; Otey, AJ; Rao, SV	1
Ariotti, S; Baldo, A; Esposito, G; Franzone, A; Gargiulo, G; Magnani, G; Marino, M; Piccolo, R; Santucci, A; Valgimigli, M; Windecker, S	1
Dong, M; Li, L; Mu, N; Ren, F; Tan, J; Zhang, C; Zhang, X	1
Aquino, M; Ariti, C; Baber, U; Bansilal, S; Chandrasekhar, J; Chieffo, A; Cohen, D; Colombo, A; Dangas, G; Faggioni, M; Farhan, S; Gabriel Steg, P; Giustino, G; Henry, T; Kini, A; Mehran, R; Michael Gibson, C; Moliterno, D; Pocock, S; Saporito, R; Sartori, S; Stuckey, T; Vogel, B; Witzenbichler, B	1
Abnousi, F; Abtan, J; Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Steg, PG; Stone, GW; White, HD	1
Bekta, P; Chmielak, Z; Debski, A; Jamiolkowski, J; Klopotowski, M; Kukula, K; Kunicki, P; Witkowski, A	1
Bhatt, DL; Deliargyris, EN; Gibson, CM; Hamm, CW; Harrington, RA; Mahaffey, KW; Prats, J; Price, MJ; Sawlani, NN; Steg, PG; Stone, GW; White, HD	1
Baber, U; Ben-Yehuda, O; Brodie, BR; Cox, DA; Duffy, PL; Henry, TD; Kirtane, AJ; Maehara, A; Mazzaferri, EL; Mehran, R; Metzger, DC; Neumann, FJ; Ooi, SY; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B; Xu, K; Yu, J	1
Cutlip, DE; D'Agostino, RB; Hsieh, WH; Kereiakes, DJ; Massaro, JM; Mauri, L; Stefanescu Schmidt, AC; Yeh, RW	1
Andrea, R; Brugaletta, S; Caixal, G; Flores-Umanzor, E; Freixa, X; Garcia, J; Hernandez-Enriquez, M; Jiménez-Brítez, G; Martin, V; Masotti, M; Regueiro, A; Sabaté, M; San Antonio, R	1
Ben-Yehuda, O; Brodie, BR; Gupta, R; Kirtane, AJ; Mehran, R; Metzger, DC; Ozan, MO; Rinaldi, MJ; Stone, GW; Stuckey, TD; Weisz, G; Witzenbichler, B	1
Jeong, MH; Joo, SJ; Kim, KS; Lim, SY	1
Antonino, MJ; Gurbel, PA; Tantry, US	1
Acar, G; Nacar, AB; Sökmen, G; Tuncer, C	1
Gerancher, JC; Kutcher, MA; Newsome, LT; Royster, RL; Weller, RS	1
Fukushima, K; Iwata, Y; Kitahara, H; Kobayashi, Y; Komuro, I; Kuroda, N; Nakayama, T; Nomura, F; Ooyama, M	1
Braun-Dullaeus, RC; Hass, N; Ibrahim, K; Kolschmann, S; Strasser, RH	1
Barthwal, R; Herman, BA	1
Angiolillo, DJ; Antman, EM; Braunwald, E; Corbalan, R; Dalby, AJ; Goodman, SG; McCabe, CH; Meisel, S; Murphy, SA; Purdy, DA; Verheugt, FW; Wiviott, SD	1
Asano, T; Fukushima, K; Ishio, N; Iwata, Y; Kitahara, H; Kobayashi, Y; Komuro, I; Kuroda, N	1
Connor, JA; Gauvreau, K; Jenkins, KJ; Maltz, LA	1
Abbott, JD; Williams, DO	1
Erdmann, E; Flesch, M; Krausgrill, B	1
Chirkov, YY; Horowitz, JD	1
Biondi-Zoccai, G; Lotrionte, M; Sheiban, I	1
Giannitsis, E; Ivandic, BT; Katus, HA; Keck, F; Kurz, K; Lehrke, S; Staritz, P	1
Damman, K; de Smet, BJ; Hillege, HL; Svilaas, T; Tijssen, JG; Vlaar, PJ; Zijlstra, F	1
Goto, S; Serebruany, VL	1
Alfonso, F; Angel, J; Bañuelos, C; Bethencourt, A; Cequier, A; Escaned, J; Hernández, R; Iñiguez, A; Jiménez-Quevedo, P; López-Mínguez, JR; Macaya, C; Martí, V; Morís, C; Pérez-Vizcayno, MJ; Sabaté, M; Suárez, A	1
Cao, Z; Cheng, WJ; Ge, HL; Guo, YH; Jia, de A; Liu, YY; Nie, B; Shi, DM; Wang, ZJ; Yan, ZX; Yang, SW; Yu, M; Zhao, YX; Zhou, YJ	1
Armero, S; Arques, S; Barragan, P; Bonello, L; Bonello, R; Burignat-Bonello, C; Camoin-Jau, L; Collet, F; Com, O; Dignat-George, F; Giacomoni, MP; Paganelli, F; Rossi, P	1
Cho, EJ; Her, SH; Jang, SW; Kim, DB; Kim, JH; Kwon, BJ; Park, CS; Park, HJ; Park, MW; Rho, TH; Shin, D	1
Barragan, P; Bonello, L; Camoin-Jau, L; De Labriolle, A; Dignat-George, F; Lemesle, G; Paganelli, F; Pakala, R; Pichard, AD; Pinto Slottow, TL; Roy, P; Scheinowitz, M; Steinberg, DH; Waksman, R	1
Bolsin, SN; Conroy, MM	1
Kremneva, LV; Shalaev, SV	1
Avanzas, P; Bayón, J; Espolita, A; García-Ruiz, JM; Hernández, E; Lozano, I; Martín, D; Rondán, J; Torres, F; Vegas, JM	1
Bonello, L; Kaneshige, K; Kent, KM; Lindsay, J; Okabe, T; Pichard, AD; Pinto Slottow, TL; Roy, P; Satler, LF; Steinberg, DH; Suddath, WO; Torguson, R; Waksman, R; Xue, Z	1
Abbate, R; Antoniucci, D; Buonamici, P; Gensini, GF; Giusti, B; Gori, AM; Marcucci, R; Paniccia, R; Saracini, C; Sestini, I	1
Jayasinghe, R; Pattullo, SJ	1
Byrne, RA; Iijima, R; Kastrati, A; Massberg, S; Mehilli, J; Neumann, FJ; Schömig, A; Schulz, S; ten Berg, JM	1
Becker, D; Beres, BJ; Fülöp, G; Kerecsen, G; Kiss, RG; Merkely, B; Preda, I; Spaulding, C; Szabó, G; Tóth-Zsamboki, E; Vargova, K	1
Cortese, B; Limbruno, U; Micheli, A; Picchi, A	1
Ben-Dor, I; Waksman, R	1
Gutkowski, W; Młodnicki, M; Wozakowska-Kapłon, B	1
Angiolillo, DJ; Brugaletta, S; Campos, B; Cola, C; Martín Yuste, V; Sabaté, M	1
Abizaid, A; Bonan, R; Costa, JR; Costa, R; Feres, F; Mattos, LA; Siqueira, D; Sousa, AG; Sousa, JE; Staico, R; Tanajura, LF	1
Collins, M; Costa, Jde R; Dangas, GD; Doi, H; Fahy, M; Kreps, EM; Lansky, AJ; Leon, MB; Liu, X; Maehara, A; Mehran, R; Mintz, GS; Moses, JW; Sano, K; Stone, GW; Weisz, G	1
Ako, J; Fitzgerald, PJ; Hirata, K; Honda, Y; Kato, H; Koo, BK; Miyoshi, N; Ogasawara, D; Otake, H; Sawada, T; Shinke, T; Shite, J; Tanino, Y	1
Motovska, Z; Widimsky, P	1
Alfonso, F; Bañuelos, C; Cazares, M; Escaned, J; Hernández, R; Jiménez-Quevedo, P; Macaya, C; Pérez-Vizcayno, MJ; Ruiz, M; Suárez, A	1
Makarov, LM; Serebruany, VL	1
Güray, U; Güray, Y; Korkmaz, S	1
Campo, G; Carletti, R; Carrescia, C; Ferrari, R; Valgimigli, M	1
Angiolillo, DJ; Brugaletta, S; Campo, G; Colangelo, S; de Cesare, N; Ferrari, R; Furgieri, A; Hamon, M; Meliga, E; Parrinello, G; Percoco, G; Repetto, A; Sabatè, M; Valgimigli, M; Vranckx, P	1
Ahn, YK; Bae, JH; Chae, IH; Chae, JK; Chen, KY; Cho, MC; Choi, DH; Chung, WS; Hong, TJ; Hur, SH; Jang, YS; Jeong, MH; Jin, Z; Kim, CJ; Kim, EJ; Kim, YJ; Li, YJ; Minami, Y; Oh, DJ; Park, CG; Park, SJ; Poddar, KL; Rha, SW; Seo, HS; Seong, IW; Seung, KB; Wang, L; Yoon, JH	1
Fernandez-Pereira, C; Llaurado, C; Mieres, J; Perez, G; Risau, G; Rodriguez, AE; Rodriguez-Granillo, AM; Rubilar, B	1
Lovric, D; Milicic, D; Skoric, B	1
Beauzile, P; Bonello, L; Gavini, R; Gurbel, P; Kaneshige, K; Kent, K; Pichard, AD; Pinto Slottow, TL; Satler, LF; Scheinowitz, M; Suddath, WO; Sushinsky, SJ; Tantry, U; Torguson, R; Waksman, R; Xue, Z	1
De Boer, MJ; Dill, T; Gosselink, AT; Hamm, C; Heestermans, AA; Hoorntje, JC; Koopmans, PC; Ten Berg, JM; Van 't Hof, AW; Van Houwelingen, G; Van Werkum, JW	1
Al Suwaidi, J; El-Menyar, A; Hussein, H	1
Akkaya, E; Ayhan, E; Bozbay, M; Ergelen, M; Orhan, AL; Osmonov, D; Sayar, N; Soylu, O; Turer, A; Uyarel, H; Yekeler, I; Yildirim, E	1
Arrebola-Moreno, AL; Melgares-Moreno, R; Ramírez-Hernández, JA; Santiago-Díaz, P	1
Alessi, MC; Bali, L; Bonnet, JL; Castelli, C; Cuisset, T; Frere, C; Gaborit, B; Morange, PE; Poyet, R; Quilici, J	1
Suttorp, MJ; van Werkum, JW; Zomer, AC; Zwart, B	1
Barillà, F; Gaudio, C; Greco, C; Mangieri, E; Pannitteri, G; Paravati, V; Pasceri, V; Pelliccia, F; Tanzilli, G	1
Cheong, SS; Cho, YH; Hong, MK; Hong, TJ; Jeong, MH; Kim, JJ; Kim, KS; Kim, YH; Lee, CW; Lee, JH; Lee, NH; Lee, SG; Lee, SH; Lim, DS; Park, DW; Park, SJ; Park, SW; Seong, IW; Seung, KB; Yang, JY; Yoon, J; Yun, SC	1
Popescu, WM	1
Abbate, R; Antoniucci, D; Buonamici, P; Carrabba, N; Cerisano, G; Gensini, GF; Giuliani, G; Marcucci, R; Migliorini, A; Parodi, G; Valenti, R	1
Howard, PA; Vacek, JL	1
Bode, C; Diehl, P; Halscheid, C; Helbing, T; Moser, M; Olivier, C	1
Bhatt, DL; Chhatriwalla, AK	1
Colombo, A; Gerber, RT	1
Barlocco, F; Caracciolo, M; D'Urbano, M; De Servi, S; Klugmann, S; Mariani, G; Nichelatti, M; Savonitto, S	1
Janion, M; Polewczyk, A; Sielski, J; Wałek, P	1
Chen, T; Cheng, XJ; Hui, J; Jiang, TB; Jiang, WP; Liu, ZH; Song, JP; Xue, F; Yang, XJ	1
Braun, S; Gebhard, D; Kastrati, A; Koch, W; Morath, T; Schömig, A; Schuster, T; Sibbing, D; Stegherr, J; von Beckerath, N	1
Steinhubl, SR	2
Carrie, D; Galinier, M; Lapeyre-Mestre, M; Montastruc, JL; Pathak, A; Tavassoli, N; Voisin, S	1
Akhter, M; Baber, U; Kini, A; Kothari, S; Sharma, SK	1
Luo, N; Nie, R; Wang, J	1
Ben-Dor, I; Pichard, AD; Waksman, R	1
Angioli, P; Bolognese, L; Carrera, A; Ducci, K; Falsini, G; Fineschi, M; Gori, T; Grotti, S; Liistro, F; Pierli, C	1
Balbi, M; Barsotti, A; Bezante, GP; Brunelli, C; Fedele, M	1
Breet, NJ; de Boer, A; Deneer, VH; Hackeng, CM; Harmsze, AM; Klungel, OH; Robijns, K; Ruven, HJ; Ten Berg, JM; van Werkum, JW	1
Afshari, A; Johansen, M; Kristensen, BB	1
Janion, M; Piatek, K; Piatek, L; Polewczyk, A; Sielski, J	1
Dziri, C; Guesmi, F; Houissa, M; Khemiri, K; Landolsi, M; Ounalli, K; Saidi, Y; Trabelsi, S	1
Schwartz, RS	1
Billinger, M; Cook, S; Eshtehardi, P; Garachemani, A; Hess, OM; Meier, B; Togni, M; Wenaweser, P; Windecker, S	1
Shen, WF	1
Chen, J; Chen, JL; Dai, J; Gao, LJ; Gao, RL; Huang, JH; Li, JJ; Liu, HB; Qiao, SB; Qin, XW; Wu, YJ; Xu, B; Yang, YJ; Yao, M; You, SJ; Yuan, JQ	1
Aichele, S; Bigalke, B; Fateh-Moghadam, S; Gawaz, M; Geisler, T; Htun, P; May, AE; Mueller, K; Ninci, E; Stellos, K	1
Price, MJ	1
Cairns, JA; Eikelboom, JW; Hirsh, J; Paikin, JS	1
Barthélémy, O; Bellemain-Appaix, A; Beygui, F; Cayla, G; Collet, JP; Hulot, JS; Montalescot, G; Pena, A; Silvain, J	1
Bigalke, B; Gawaz, M; Geisler, T; Hövelborn, T; May, AE	1
Kastrati, A; Schömig, A; Schulz, S; Sibbing, D; Steinhubl, SR	1
Wessely, R	1
Ahmet, G; Bitigen, A; Can, MM; Karabay, CY; Serebruany, V; Tanboğa, IH	1
Braun, S; Byrne, RA; Kastrati, A; Massberg, S; Mehilli, J; Morath, T; Schömig, A; Schulz, S; Sibbing, D	1
Huang, Y; Khalil, M; Penn, MS; van Giezen, JJ; Wang, K; Wiktor, D; Zhou, X	1
Angiolillo, DJ; Becker, R; Bhatt, DL; Blindt, R; Bonello, L; Cattaneo, M; Collet, JP; Cuisset, T; Gachet, C; Gurbel, PA; Jennings, LK; Kereiakes, D; Marcucci, R; Montalescot, G; Paganelli, F; Price, MJ; Sibbing, D; Tantry, US; Trenk, D; Van Werkum, JW; Waksman, R	1
Ferrandis, R; Gómez-Luque, A; Llau, JV; Sierra, P	1
Aakhus, S; Arnesen, H; Bjørnerheim, R; Forfang, K; Lunde, K; Seljeflot, I; Solheim, S	1
Ardissino, D; Becker, RC; Cannon, CP; Emanuelsson, H; Finkelstein, A; Harrington, RA; Husted, S; James, S; Katus, H; Kilhamn, J; Olofsson, S; Steg, PG; Storey, RF; Wallentin, L; Weaver, WD	1
Reinhart, WH	1
Gentilomo, C; Huang, YS; Raffini, L	1
Chubachi, H; Ikee, R; Miyasaka, Y; Saito, S; Yasu, T	1
Angiolillo, DJ; Tello-Montoliu, A; Tomasello, SD	1
Ahn, Y; Cho, JG; Hong, YJ; Jeong, MH; Kang, JC; Kim, JH; Kim, KH; Ko, JS; Lee, MG; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS	1
Rechner, AR	1
Frey, N; Ivandic, B	1
Dolgin, E	1
Campbell, KL; Cohn, JR; Fischman, DL; Jaffrani, W; Mallya, R; Savage, MP; Walinsky, P	1
Di Sciascio, G; Pasceri, V; Patti, G; Ricottini, E; Vizzi, V	1
Jung, HJ; Sir, JJ	1
Barison, A; Bellini, F; Capozza, PF; de Carlo, M; Lunardini, A; Petronio, AS	1
Bakhai, A; Belger, M; Ferrieres, J; Iñiguez, A; Sartral, M; Schmitt, C; Zeymer, U	1
Jensen, SE; Juel, J	1
Bouman, HJ; Breet, NJ; Hackeng, CM; ten Berg, JM; ten Cate, H; van Werkum, JW	1
White, HD	1
Bernlochner, I; Kastrati, A; Mehilli, J; Morath, T; Neumann, L; Sarafoff, N; Schömig, A; Sibbing, D	1
Matthai, WH; Patel, PJ; Untereker, WJ	1
Gachet, C; Hechler, B	1
Brodie, BR; Caixeta, A; Cristea, E; Dangas, GD; Dudek, D; Guagliumi, G; Lansky, AJ; Mehran, R; Möeckel, M; Parise, H; Peruga, JZ; Stone, GW; Witzenbichler, B	1
Briongos Figuero, S; de Juan-Bagudá, J; Martí-Sánchez, D; Salido-Tahoces, L	1
Dart, AM; Fernando, H; Peter, K; Shaw, JA	1
Archontakis, S; Gafou, A; Kalogeras, KI; Kariori, MG; Moldovan, C; Papaioannou, TG; Stefanadis, C; Tzamalis, P; Vavuranakis, M; Vrachatis, DA	1
Byrne, RA; Hausleiter, J; Laugwitz, KL; Orban, M; Sibbing, D	1
Alfieri, A; Bellone, P; Berti, S; Cassese, S; De Luca, G; Marraccini, P; Montinaro, A; Piscione, F; Quaranta, G; Villari, B	1
Columbo, J; Cui, J; Davis, M; Giugliano, GR; Lotfi, A; Mulvey, S; Schweiger, M; Wartak, S	1
Ajani, AE; Andrianopoulos, N; Brennan, AL; Clark, DJ; Duffy, SJ; Loane, P; Reid, CM; Yan, BP	1
Nusca, A; Patti, G	1
Curzen, N; Sambu, N	1
Erlinge, D; James, S; Koul, S; Lagerqvist, B; Siegbahn, A; Varenhorst, C; Wallentin, L	1
Barone-Rochette, G; Danchin, N; Foote, A; Machecourt, J; Motreff, P; Quesada, JL; Vanzetto, G	1
Alfonso, F; Fernandez-Ortiz, A; Zakhem, B	1
Davis, G; Garg, P; Sivananthan, M; Wilson, JI	1
Forrester, JS; Sharma, S	1
Angiolillo, DJ; Capodanno, D; Gavazzi, A; Guagliumi, G; Lettieri, C; Musumeci, G; Romano, M; Rosiello, R; Rossini, R; Valsecchi, O	1
Hu, B; Luo, Y; Qi, WG; Verdo, A; Zhang, DF; Zhao, YT	1
Fischerova, M; Maly, M; Morawska, P; Motovska, Z; Odvodyova, D; Stepankova, S; Widimsky, P	1
Breet, NJ; Dambrink, JH; Gosselink, AT; Hamm, C; Hermanides, RS; Ottervanger, JP; ten Berg, JM; van 't Hof, AW; van Houwelingen, KG; van Werkum, JW	1
Iino, K; Ishida, M; Ito, H; Kosaka, T; Okawa, M; Watanabe, H	1
Becker, RC; Cutlip, DE; Dauerman, HL; French, PA; Granada, JF; Price, MJ; Smyth, SS; Steinhubl, SR	1
Kern, MJ	1
Buntic, R; Parrett, BM; Singer, M; Woo, A	1
Elmariah, S; Jang, IK	1
Kirkby, NS; Mitchell, JA; Warner, TD	1
Calver, AL; Corbett, S; Curzen, N; Dent, H; Gray, H; Radhakrishnan, A; Sambu, N; Simpson, IA	1
Kalidoss, L; Sankardas, MA; Subban, V	1
Angiolillo, DJ; Azmoon, S	1
Hwang, JY; Hwang, SJ; Jeong, YH; Koh, JS; Kwak, CH; Kwon, TJ; Muse, WC; Park, Y	1
Atalar, E; Canpolat, U; Yorgun, H	1
Chmiel, A; Gąsior, Z; Gieszczyk, K; Haberka, M; Kunecki, M; Kyrcz-Krzemień, S; Lasota, B; Mizia, M; Mizia-Stec, K; Najda, J	1
Cayla, G; Collet, JP; Hulot, JS; Montalescot, G; O'Connor, SA; Silvain, J	1
Bessereau, J; Bonello, L; Camoin-Jau, L; Laine, M; Paganelli, F; Sébastien, A	1
Alexopoulos, D; Damelou, A; Davlouros, P; Galati, A; Hahalis, G; Kassimis, G; Makris, G; Mavronasiou, E; Theodoropoulos, KC; Tsigkas, G; Xanthopoulou, I	1
Chan, KH; Chan, MY; Lee, CH; Li, Y; Low, A; Phua, QH; Richards, MA; Roe, MT; Sia, W; Sim, TB; Tai, BC; Tan, HC; Teo, SG; Yeo, TC	1
Boggi, A; Colantonio, R; Monti, F; Rotolo, F; Serdoz, R	1
Angiolillo, DJ; Rollini, F; Tello-Montoliu, A	1
El Mallah, W; Moliterno, DJ	1
Brilakis, ES; Klein, AJ	1
Boden, H; Guchelaar, HJ; Heijmans, BT; Jukema, JW; Putter, H; Schalij, MJ; Trompet, S; van der Hoeven, BL; Verschuren, JJ; Wessels, JA	1
Chen, SL; Lin, L; Lin, S; Tan, J; Wang, GJ; Xie, HG; Xu, HM; Zhang, J; Zhao, YY; Zou, JJ	1
Brodie, B; Cooper, M; Garg, A; Hansen, C; Kissling, G; McAlhany, C; Milks, S; Pokharel, Y; Stuckey, T	1
Biscaglia, S; Campo, G; Tebaldi, M; Valgimigli, M; Vranckx, P	1
Abtan, J; Aubry, P; Barthélémy, O; Belle, L; Beygui, F; Boueri, Z; Carrié, D; Cayla, G; Collet, JP; Cuisset, T; Elhadad, S; Henry, P; Kerneis, M; Monségu, J; Montalescot, G; Motreff, P; O'Connor, SA; Pouillot, C; Rangé, G; Rousseau, H; Sabouret, P; Saint-Etienne, C; Silvain, J; Van Belle, E; Vicaut, E	1
Arméro, S; Bonello, L; Laine, M; Paganelli, F; Peyrol, M; Sbragia, P; Thuny, F	1
Bennett, MR	1
Gao, RL; Han, YL; Jiang, TM; Jing, QM; Li, SM; Li, WM; Li, Y; Liu, HL; Qu, P; Xu, B; Yang, LX; Zhang, L; Zhang, QY	1
Aradi, D; Komócsi, A; Serebruany, VL; Vorobcsuk, A	1
Hamanaka, I; Hara, K; Ishiwata, S; Itoh, T; Kawai, K; Kimura, T; Nakamura, M; Sugano, T; Ueno, T; Wakatsuki, T; Yamagishi, M	1
Fujimoto, Y; Iwata, Y; Kadohira, T; Kitahara, H; Kobayashi, Y; Morino, T; Ohkubo, K; Sugimoto, K	1
Antonino, M; Bliden, KP; Chai, S; Fort, JG; Gesheff, M; Gesheff, T; Gurbel, PA; Jeong, YH; Shuldiner, A; Tantry, US; Zhang, Y	1
Anderson, JL; Carlquist, JF; Horne, BD; Huntinghouse, JA; Knight, S; May, H; Muhlestein, JB; Rollo, JS	1
Berg, R; Bolla, VH; Singh, M	1
Brinker, A; Schech, SD; Shatin, D	1
Adgey, JA; Khan, MM; Mahadevan, VS	1
Boccanelli, A; Burzotta, F; Grollier, G; Hamon, M; Prati, F; Sabatier, R	1
Bell, MR; Berger, PB; Fasseas, P; Holmes, DR; Lennon, R; Melby, S; Orford, JL; Rihal, CS	1
Fitchett, D; Goodman, SG; Gupta, M; Langer, A	1
Dühmke, E; Kantlehner, R; Klauss, V; König, A; Krötz, F; Pöllinger, B; Rieber, J; Schiele, TM; Sohn, HY; Theisen, K; Zahler, S	1
Alford, AB; Bell, CR; Cummings, CC; Gurbel, PA; Meister, AF; Serebruany, VL	1
Boden, WE; Pepine, CJ	1
Mehta, SR; Yusuf, S	1
Barragan, P; Bouvier, JL; Camoin, L; Comet, B; Commeau, P; Eigenthaler, M; Lafont, A; Macaluso, G; Roquebert, PO; Walter, U	1
Rebrov, AP; Voskoboĭ, VI	1
Rott, D	1
Colombo, A; Desmedt, B; Di Mario, C; Holmes, DR; Leon, MB; Louvard, Y; Ludwig, J; Morice, MC; Moses, JW; Spanos, V	1
Christ, G; Fritsch, P; Heinze, G; Huber, K; Kyrle, PA; Schoenauer, V; Weltermann, A; Wojta, J	1
Kastrati, A; Schömig, A; Schömig, E	1
Heikkilä, J; Lassila, R; Lepäntalo, A; Virtanen, KS; Wartiovaara, U	1
Berger, PB	2
Angiolillo, DJ; Bernardo, E; Jiménez-Quevedo, P; Sabaté, M	1
Alfonso, F; Angiolillo, DJ; Bernardo, E; Fernández, C; Fernandez-Ortiz, A; Macaya, C; Pignatti, PF; Sabaté, M; Stranieri, C; Trabetti, E	1
Helø, OH; Kastrup, J; Madsen, JK	1
Beinart, R; Bienart, R; Goldenberg, I; Guetta, V; Hod, H; Matetzky, S; Novikov, I; Pres, H; Savion, N; Shechter, M; Shenkman, B; Varon, D	1
Besta, F; Gawaz, M; Müller, I	1
Tsakiris, DA	1
Schneider, C	1
Coller, B; FitzGerald, GA; Hirsh, J; Patrono, C; Roth, G	1
Becker, RC; Ezekowitz, M; Guyatt, GH; Harrington, RA; Meade, TW; O'Connor, CM; Vorchheimer, DA	1
De Caterina, R; Maddestra, N; Renda, G; Zimarino, M	1
Schwimmbeck, PL	1
Schulman, SP	1
Heidenreich, PA; Olkin, I; Schleinitz, MD	1
Eich, A; Münzel, T; von Mach, MA; Weilemann, LS	1
Bliden, KP; Gurbel, PA; Hayes, KM; Tantry, US; Yoho, JA; Zaman, KA	1
Antman, EM; Leopold, JA	1
Bavry, AA; Bhatt, DL; Helton, TJ; Kumbhani, DJ	1
Kunz, I; Ruggieri, F; Spada, S; Sütsch, G	1
Karvouni, E; Katritsis, DG; Korovesis, S	1
Roffi, M; Wyss, CA	1
Agostoni, P; Airoldi, F; Barbagallo, R; Biondi-Zoccai, GG; Briguori, C; Carlino, M; Chieffo, A; Colombo, A; Falchetti, E; Iakovou, I; Margheri, M; Melzi, G; Michev, I; Montorfano, M; Remigi, E; Sangiorgi, GM; Tamburino, C; Tsagalou, E; Vittori, G	1
Amit, G; Cafri, C; Gilutz, H; Ilia, R; Wolak, A; Zahger, D	1
Andre, P; Conley, PB; Phillips, DR; Sinha, U	1
Bliden, KP; Gurbel, PA; Tantry, US	1
Antman, EM; Braunwald, E; Cannon, CP; Dellborg, M; Gibson, CM; Keltai, M; Leiva-Pons, JL; McCabe, CH; Montalescot, G; Morrow, DA; Murphy, SA; Sabatine, MS	1
Almsherqi, ZA; Deng, Y; McLachlan, CS; Mossop, P	1
Holmes, DR	2
Berg, O; Bierbach, B; Darius, H; Heimann, A; Horstick, G; Kempski, O; Münzel, T; Vahl, CF	1
Brügemann, J; van der Meer, J; van Gelder, IC; Zijlstra, F	1
Barutcu, I; Boztosun, B; Gunes, Y; Kirma, C	1
Brooks, JM; Crandall, DL; Hennan, JK; Leik, CE; Morgan, GA; Schaub, RG; Shaw, GD; Swillo, RE; Vlasuk, GP	1
Hocking, WG; Rezkalla, SH; Vats, HS	1
Drexler, H; Schaefer, A; Stumme, B; Templin, C; von Depka, M	1
Hollman, JL; Olivier, AC	1
Bugra, Z; Ekmekci, A; Meric, M; Ozben, B; Umman, S	1
Oo, TH	1
Kreindel, M; Lincoff, AM; Patel, TN	1
Aroesty, JM; Cannon, CP; Gibson, CM; Kirtane, AJ; Murphy, SA; Sabatine, MS; Vafai, JJ	1
Granitskiĭ, NA	1
Heestermans, AA; Plokker, HW; ten Berg, JM; van Werkum, JW	1
Faxon, DP; Nesto, RW	1
Chrissoheris, MP; Donohue, TJ; Mruthyunjayanna, V	1
Erdmann, E	1
Ling, F; Wang, N; Xu, J; Yang, J; Ye, X; Zhang, X; Zhou, L	1
Münzel, TF; Post, F	1
Aslani, A; Sharifkazemi, MB; Zamirian, M	1
Bader, F; Brunner-La Rocca, HP; Buser, PT; Hunziker, P; Jeger, R; Kaiser, C; Mueller, C; Osswald, S; Pfisterer, M; Rickenbacher, P	1
Califf, RM; Harrington, RA	1
Cattaneo, M	1
Roberts, DH; Wiper, AJ	1
Antoniou, S; Rothman, MT	1
Chassot, PG; Delabays, A; Ravussin, P; Spahn, DR	1
Filipiak, KJ; Glowczynska, R; Grabowski, M; Kisiel, B; Kochman, J; Kostrzewa, G; Malek, LA; Opolski, G; Ploski, R; Spiewak, M	1
Hamdalla, H; Steinhubl, SR	1
Amin, S; Diamond, GA; Eshaghian, S; Kaul, S; Shah, PK	1
Bal, ET; den Heijer, P; Seesing, TH; Suttorp, MJ; Ten Berg, JM; van Werkum, JW	1
Grinius, V; Navickas, R; Unikas, R	1
Bartorelli, AL; Benassi, A; Chierchia, S; Di Mario, C; Galassi, A; Piovaccari, G; Reimers, B; Sangiorgio, P; Serdoz, R; Sheiban, I; Tamburino, C; Trabattoni, D; Zimarino, M	1
Finn, AV; Gold, HK; John, MC; Joner, M; Kolodgie, F; Nakazawa, G; Newell, J; Virmani, R	1
Cohen, MG; Dunn, SP; Lee, JS; Marshall, HM; Smyth, SS	1
Bauersachs, J; Bonz, AW; Eigenthaler, M; Schäfer, A	1
Breall, JA; Kalaria, V; Karlsson, G; Rehman, J	1
Fefer, P; Hod, H; Matetzky, S	1
Aubry, P; Benamer, H; Ducrocq, G; Feldman, LJ; Himbert, D; Juliard, JM; Majdoub, MA; Sauguet, A; Steg, PG; Tchetche, D	1
Dib, JC; Digne, F; Dubois, C; Estagnasié, P; Gérardin, B; Grinda, JM; Pillière, R; Terdjman, M	1
Baer, FM; Erdmann, E	1
Kay, P; Tie, S; Wilkins, G; Williams, M; Wong, CK; Yap, J	1
Gladding, P; Webster, M	1
Aurier, E; Benassi, A; Cremonesi, A; Grilli, R; Guastaroba, P; Magnavacchi, P; Manari, A; Maresta, A; Marzocchi, A; Percoco, G; Piovaccari, G; Saia, F; Varani, E	1
Bigalke, B; Daub, K; Dösch, C; Gawaz, M; Geisler, T; Göhring-Frischholz, K; Herdeg, C; Kapp, M; Langer, H	1
Belli, G; Presbitero, P; Rossi, M; Zavalloni, D	1
Amorn, AM; Cercek, B; Dohad, S; Forrester, JS; Kapoor, N; Kar, S; Kupferwasser, LI; Lee, MS; Makkar, RR; Mirocha, J; Shah, PK	1
Beckman, JA; Parikh, SA	1
Chassot, PG; Delabays, A; Spahn, DR	1
Bucciarelli-Ducci, C; Colantonio, R; Fedele, F; Mancone, M; Sangiorgi, GM; Sardella, G	1
Knapp, M; Musiał, WJ; Prokop, JB; Sawicki, R; Sobkowicz, B; Tomaszuk-Kazberuk, A; Usowicz-Szaryńska, M	1
Collet, JP; Montalescot, G	1
Augoustides, JG	1
Joyal, D; Rudski, L	1
Okabe, T; Pichard, AD; Pinto Slottow, TL; Roy, P; Satler, LF; Smith, K; Steinberg, DH; Torguson, R; Waksman, R; Xue, Z	1
De Caterina, R; Renda, G; Zimarino, M	1
Diez, J; Ferguson, JJ; Wilson, JM	1
Banning, AP; Buellesfeld, L; Colombo, A; Dawkins, KD; Grube, E; Guagliumi, G; Hauptman, K; Koglin, J; Marco, J; Popma, JJ; Russell, ME; Thuesen, L; Wijns, W; Zmudka, K	1
Fitzgerald, DJ; Maree, A	1
Berger, K; Diener, HC; Hessel, F; Kreuzer, J; Smala, A	1
Huber, K; Schrör, K	1
Herman, A; Matejka, J; Varvarovský, I	1
Black, SA; Bolsin, SN; Conroy, M; Orford, N	1
Durakoglugil, E; Kaya, MG; Yalcin, R	1
Arora, R; Bahekar, A; Handa, K; Khosla, S; Khraisat, A; Singh, S; Trivedi, A	1
Boval, B; Drouet, L; Kirsch, M; Loisance, D; Vermes, E	1
Dupliakov, DV	1
Endemann, S; Ernst, A; Gollapudi, RR; Levisay, JP; Price, MJ; Sawhney, NS; Schatz, RA; Stinis, CT; Teirstein, PS; Valencia, R	1
Fineschi, M; Gori, T	1
Banning, AP; Ryding, AD	1
Bertrand, OF; Costerousse, O; De Larochellière, R; Déry, JP; Faurie, B; Gleeton, O; Larose, E; Nguyen, CM; Noël, B; Proulx, G; Rodés-Cabau, J; Roy, L	1
Beyar, R; Nikolsky, E	1
Biondi-Zoccai, GG; Bollati, M; Gambino, A; Lombardi, P; Sheiban, I	1
Eshtehardi, P; Eslami, M; Moayed, DA	1
Azzari, F; Berry, C; Doucet, S; Ducrocq, G; Grégoire, JC; Ibrahim, R; L'Allier, PL; Labarthe, B; Noble, S; Nozza, A; Pranno, N; Tardif, JC; Théroux, P	1
Caputo, RP; Cohen, DJ; Cutlip, DE; Dauerman, HL; Gibson, CM; Gordon, PC; Ho, KK; Kiernan, FJ; Kirtane, AJ; Lopez, JJ; Murphy, SA; Piana, RN; Rinaldi, MJ; Ryan, TJ	1
Sharma, M; Yeghiazarians, Y	1
Holloway, D; Sullebarger, JT; Wymer, N	1
Barone-Rochette, G; Bertrand, B; Machecourt, J; Ormezzano, O; Polack, B; Vanzetto, G	1
Al Ali, A; Andrade, J; Saw, J; Wong, GC	1
King, SB	1
Anderson, HV; Buja, LM; Ferguson, JJ; Maffrand, JP; Ober, JC; Willerson, JT; Yao, SK	2
Schrör, K; Weber, AA	1
Collins, M; Colombo, A; Iyer, S; Kreps, E; Maida, R; Moses, JW; Moussa, I; Oetgen, M; Roubin, G; Wang, X	1
Steinhubl, SR; Topol, EJ	1
Marks, KR; McCullough, PA	1
de Carvalho, HC	1
Willerson, JT; Zoldhelyi, P	1
Bergman, G; Deutsch, E; Jauhar, R; Parikh, M; Sanborn, TA; Savino, S; Shaknovich, A	1
Aguirre, FV; Ligon, RW; Lucore, CL; Mishkel, GJ; Rocha-Singh, KJ	1
Barsness, G; Bell, MR; Bellot, V; Berger, PB; Garratt, K; Grill, D; Hammes, L; Holmes, DR; Mathew, V; Melby, S; Rihal, CS; Ting, H	1
Calvin, JE; Klein, LW	1
Büttner, HJ; Müller, C; Petersen, J; Roskamm, H	1
Miller, JL	1
Cohen, M	1
Dillon, JC; Dillon, WC; Eckert, GJ; Ritchie, ME	1
Gawaz, M; Müller, I; Pogatsa-Murray, G; Rüdiger, S; Schömig, A; Seyfarth, M; Wolf, B	1
Steinhubl, SR; Van De Graaff, E	1
Behar, VS; Broderick, T; Colombo, A; Kandzari, DE; Kereiakes, DJ; Kern, M; Runyon, JP; Safian, RD; Shimshak, T; Sketch, MH; Young, J	1
Kurz, HI; Lasala, JM; Taniuchi, M	1
Chesterman, CN; Fahmy, RG; Khachigian, LM; Kumar, RK; Lowe, HC	1
Dangas, G	1
Berger, PB; Bertrand, ME; Bhatt, DL; Dangas, G; Ellis, SG; Holmes, DR; L'Allier, PL; Lasala, JM; Moses, JW; Moussa, I; Taniuchi, M; Topol, EJ	1
Driscoll, E; Hasa, AA; Lucchesi, BR; Normolle, D; Schmaier, AH; Warnock, M; Werns, SW	1
Bahit, MC; Granger, CB; Wallentin, L	1

Reviews

76 review(s) available for clopidogrel and Coronary Thrombosis

Article	Year
Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials. BMC cardiovascular disorders, 2017, 06-15, Volume: 17, Issue:1 Topics: Acute Coronary Syndrome; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Hemorrhage; Humans; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Precision Medicine; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Risk Factors; Ticlopidine; Treatment Outcome	2017
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis. JACC. Cardiovascular interventions, 2017, 08-28, Volume: 10, Issue:16 Topics: Aged; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2017
Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis. BMC cardiovascular disorders, 2018, 05-02, Volume: 18, Issue:1 Topics: Administration, Oral; Aged; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Stroke; Time Factors; Treatment Outcome	2018
Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects. Archives of cardiovascular diseases, 2013, Volume: 106, Issue:10 Topics: Aryl Hydrocarbon Hydroxylases; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Resistance; Genotype; Humans; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation Inhibitors; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2013
Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons. Current medical research and opinion, 2014, Volume: 30, Issue:1 Topics: Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Tetrazoles; Ticlopidine; Treatment Outcome	2014
Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation. European heart journal, 2014, Aug-01, Volume: 35, Issue:29 Topics: Aspirin; Blood Vessel Prosthesis; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Failure; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome; Withholding Treatment	2014
New antiplatelet agents in the treatment of acute coronary syndromes. Archives of cardiovascular diseases, 2014, Volume: 107, Issue:3 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Clinical Trials as Topic; Clopidogrel; Combined Modality Therapy; Coronary Artery Bypass; Coronary Thrombosis; Diabetes Complications; Hemorrhage; Humans; Multicenter Studies as Topic; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Precision Medicine; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Renal Insufficiency; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2014
How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors--is an algorithm the answer? Thrombosis and haemostasis, 2015, Volume: 113, Issue:1 Topics: Algorithms; Animals; Blood Platelets; Clopidogrel; Coronary Thrombosis; Decision Support Techniques; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Pharmacogenetics; Platelet Aggregation Inhibitors; Platelet Function Tests; Precision Medicine; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Ticlopidine; Treatment Outcome	2015
Ticagrelor: a safe and effective approach for overcoming clopidogrel resistance in patients with stent thrombosis? Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2016, Volume: 27, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2; Stents; Ticagrelor; Ticlopidine	2016
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis. JACC. Cardiovascular interventions, 2016, 05-23, Volume: 9, Issue:10 Topics: Adenosine; Antithrombins; Bayes Theorem; Blood Platelets; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Evidence-Based Medicine; Hirudins; Humans; Markov Chains; Monte Carlo Method; Network Meta-Analysis; Odds Ratio; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Recombinant Proteins; Risk Factors; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Treatment Outcome	2016
Antiplatelet treatment of cardiovascular disease: a translational research perspective. Polskie Archiwum Medycyny Wewnetrznej, 2008, Volume: 118, Issue:5 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine	2008
Coronary artery stents: II. Perioperative considerations and management. Anesthesia and analgesia, 2008, Volume: 107, Issue:2 Topics: Anesthesia, Conduction; Angioplasty, Balloon, Coronary; Aspirin; Blood Loss, Surgical; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Coronary Vessels; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Stents; Surgical Procedures, Operative; Ticlopidine	2008
Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review. Circulation, 2008, Oct-28, Volume: 118, Issue:18 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Thrombosis; Electrocardiography; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine	2008
Emergence of the concept of platelet reactivity monitoring of response to thienopyridines. Heart (British Cardiac Society), 2009, Volume: 95, Issue:15 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2 Receptor Antagonists; Pyridines; Ticlopidine	2009
[Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction]. Terapevticheskii arkhiv, 2008, Volume: 80, Issue:12 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine	2008
Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization. Vascular health and risk management, 2009, Volume: 5, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Diabetes Mellitus, Type 2; Drug-Eluting Stents; Female; Humans; Medication Adherence; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Sirolimus; Ticlopidine; Treatment Outcome	2009
Improving outcomes in patients undergoing percutaneous coronary intervention: role of prasugrel. Vascular health and risk management, 2009, Volume: 5, Issue:1 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Diabetes Complications; Drug Resistance; Drug Therapy, Combination; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; Stents; Thiophenes; Ticlopidine; Treatment Outcome	2009
[Clopidogrel resistance]. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2009, Volume: 9, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2009
Coronary stent thrombosis in patients with chronic renal insufficiency. Angiology, 2010, Volume: 61, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Insufficiency, Chronic; Risk Factors; Stents; Ticlopidine	2010
Combined mechanical and pharmacological approach to a thrombus-containing lesion. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, May-01, Volume: 75, Issue:6 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Coronary Vessels; Dilatation, Pathologic; Eptifibatide; Filtration; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Thrombectomy; Thrombolytic Therapy; Ticlopidine; Ultrasonography, Interventional	2010
[Discontinuation of treatment with platelet aggregation inhibitors in surgical patients with cardiac stents]. Ugeskrift for laeger, 2010, Mar-15, Volume: 172, Issue:11 Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Loss, Surgical; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Elective Surgical Procedures; Emergencies; Evidence-Based Medicine; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Practice Guidelines as Topic; Risk Assessment; Stents; Ticlopidine; Time Factors	2010
New antithrombotic agents--insights from clinical trials. Nature reviews. Cardiology, 2010, Volume: 7, Issue:9 Topics: Adenosine; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Coumarins; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine	2010
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C192 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis. Journal of the American College of Cardiology, 2010, Jul-06, Volume: 56, Issue:2* Topics: Alleles; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 Enzyme System; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Sensitivity and Specificity; Stents; Ticlopidine	2010
Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update. Vascular health and risk management, 2010, Oct-05, Volume: 6 Topics: Aspirin; Blood Loss, Surgical; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Humans; Myocardial Revascularization; Perioperative Care; Perioperative Period; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine	2010
Prasugrel for the treatment of coronary thrombosis: a review of pharmacological properties, indications for use and future development. Expert opinion on investigational drugs, 2011, Volume: 20, Issue:1 Topics: Animals; Clopidogrel; Coronary Thrombosis; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine	2011
Platelet function testing in clinical diagnostics. Hamostaseologie, 2011, May-02, Volume: 31, Issue:2 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Hemorrhage; Humans; Intracranial Embolism; Intracranial Thrombosis; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Ticlopidine	2011
[New approaches and indications for the analysis of platelet function in cardiology]. Hamostaseologie, 2011, May-02, Volume: 31, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Interactions; Hemorrhage; Humans; Piperazines; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine	2011
Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy. Thrombosis and haemostasis, 2011, Volume: 105, Issue:6 Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Interactions; Enzyme Activation; Genetic Testing; Humans; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Postoperative Complications; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome	2011
Platelet-mediated thrombosis and drug-eluting stents. Circulation. Cardiovascular interventions, 2011, Dec-01, Volume: 4, Issue:6 Topics: Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Equipment Design; Humans; Piperazines; Platelet Activation; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Risk Factors; Thiophenes; Ticlopidine	2011
Switching antiplatelet regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI: a review of the literature and practical considerations for the interventional cardiologist. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Volume: 81, Issue:2 Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Pharmacogenetics; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome	2013
Pharmacogenetics of clopidogrel. Current pharmaceutical design, 2012, Volume: 18, Issue:33 Topics: Aryl Hydrocarbon Hydroxylases; Biotransformation; Blood Platelets; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Resistance; Genetic Testing; Genotype; Humans; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2012
Tailoring antiplatelet therapy: a step toward individualized therapy to improve clinical outcome? Current pharmaceutical design, 2012, Volume: 18, Issue:33 Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Blood Platelets; Clopidogrel; Coronary Thrombosis; Drug Interactions; Drug Resistance; Genotype; Hemorrhage; Humans; Patient Selection; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Precision Medicine; Predictive Value of Tests; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2012
Clinical impact of genetically determined platelet reactivity. Journal of cardiovascular translational research, 2013, Volume: 6, Issue:3 Topics: Animals; Aryl Hydrocarbon Hydroxylases; Biotransformation; Blood Platelets; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Resistance; Genotype; Humans; Patient Selection; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Precision Medicine; Stents; Ticlopidine; Treatment Outcome	2013
The discovery of a new class of synaptic transmitters in smooth muscle 50 years ago and amelioration of coronary artery thrombosis. Acta physiologica (Oxford, England), 2013, Volume: 207, Issue:2 Topics: Adenosine; Animals; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; History, 20th Century; Humans; Muscle, Smooth; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y; Ticagrelor; Ticlopidine	2013
Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Thrombosis and haemostasis, 2013, Volume: 109, Issue:1 Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Coronary Thrombosis; Female; Humans; Intracranial Hemorrhages; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Stroke; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2013
Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes. The Canadian journal of cardiology, 2002, Volume: 18, Issue:11 Topics: Acute Disease; Algorithms; Clopidogrel; Coronary Disease; Coronary Thrombosis; Enoxaparin; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk Factors; Ticlopidine	2002
Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. Journal of the American College of Cardiology, 2003, Feb-19, Volume: 41, Issue:4 Suppl S Topics: Acute Disease; Administration, Oral; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Myocardial Infarction; Outcome Assessment, Health Care; Platelet Activation; Platelet Aggregation Inhibitors; Ticlopidine	2003
[Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel]. Ugeskrift for laeger, 2004, Apr-26, Volume: 166, Issue:18 Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Stroke; Ticlopidine	2004
Combined antithrombotic therapy for acute coronary syndrome. Seminars in vascular medicine, 2003, Volume: 3, Issue:2 Topics: Administration, Oral; Angina, Unstable; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine	2003
Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, Volume: 126, Issue:3 Suppl Topics: Antithrombins; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Electrocardiography; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Assessment; Ticlopidine	2004
Cilostazol, clopidogrel or ticlopidine to prevent sub-acute stent thrombosis: a meta-analysis of randomized trials. American heart journal, 2004, Volume: 148, Issue:6 Topics: Anticoagulants; Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Tetrazoles; Ticlopidine; Warfarin	2004
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. Journal of the American College of Cardiology, 2005, Mar-15, Volume: 45, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2005
Platelet inhibition in percutaneous coronary interventions. Herz, 2005, Volume: 30, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Premedication; Ticlopidine	2005
Therapeutic approaches in arterial thrombosis. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:8 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Atherosclerosis; Blood Platelets; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Disease Progression; Fibrinolytic Agents; Humans; Mice; Models, Biological; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Risk; Signal Transduction; Thrombosis; Ticlopidine; Time Factors	2005
[Cardiological (pharmaco)therapy and dental practice]. Nederlands tijdschrift voor tandheelkunde, 2006, Volume: 113, Issue:2 Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Thrombosis; Defibrillators, Implantable; Heart Valve Prosthesis; Humans; Oral Surgical Procedures; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Ticlopidine	2006
Multiple coronary thrombosis and stent implantation to the subtotally occluded right renal artery in a patient with essential thrombocytosis: a case report with review. Journal of thrombosis and thrombolysis, 2006, Volume: 22, Issue:1 Topics: Angina, Unstable; Angioplasty; Clopidogrel; Coronary Thrombosis; Female; Humans; Hypertension; Middle Aged; Platelet Aggregation Inhibitors; Renal Artery Obstruction; Thrombocythemia, Essential; Thrombosis; Ticlopidine	2006
Drug insight: Clopidogrel nonresponsiveness. Nature clinical practice. Cardiovascular medicine, 2006, Volume: 3, Issue:7 Topics: Clopidogrel; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2006
[Pathogenesis and therapy of the acute coronary syndrome: differentiated advantage of glycoprotein IIb/IIIa receptor antagonists for high-risk patients]. Deutsche medizinische Wochenschrift (1946), 2006, Nov-24, Volume: 131, Issue:47 Suppl 7 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Thrombosis; Diabetes Complications; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Renal Insufficiency; Risk Factors; Syndrome; Ticlopidine; Tirofiban; Troponin; Tyrosine	2006
Platelet P2 receptors: old and new targets for antithrombotic drugs. Expert review of cardiovascular therapy, 2007, Volume: 5, Issue:1 Topics: Adenosine; Adenosine Monophosphate; Angina, Unstable; Animals; Blood Platelets; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Interactions; Fibrinolytic Agents; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2X; Syndrome; Thiophenes; Ticagrelor; Ticlopidine	2007
[Antiplatelet drugs and intraoperative hemorrhage]. Revue medicale suisse, 2006, Nov-22, Volume: 2, Issue:88 Topics: Algorithms; Aspirin; Blood Loss, Surgical; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Intraoperative Period; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Ticlopidine	2006
Oral antiplatelet therapy for percutaneous coronary revascularization. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Apr-01, Volume: 69, Issue:5 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyridines; Ticlopidine	2007
Role of clopidogrel in managing atherothrombotic cardiovascular disease. Annals of internal medicine, 2007, Mar-20, Volume: 146, Issue:6 Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2007
[Stents in interventional cardiology]. Medicina (Kaunas, Lithuania), 2007, Volume: 43, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Diabetes Complications; Drug Delivery Systems; Drug Therapy, Combination; Fibrinolytic Agents; Follow-Up Studies; Humans; Immunosuppressive Agents; Middle Aged; Platelet Aggregation Inhibitors; Prednisolone; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome	2007
Clopidogrel resistance--the cardiologist's perspective. Platelets, 2007, Volume: 18, Issue:3 Topics: Blood Platelets; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine	2007
[Very late intrastent thrombosis--at 27 months!]. Archives des maladies du coeur et des vaisseaux, 2007, Volume: 100, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Fatal Outcome; Flurbiprofen; Follow-Up Studies; Hernia, Inguinal; Humans; Laparoscopy; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine	2007
[Dual platelet aggregation inhibition in coronary artery stent implantation--what is evidence-based?]. Deutsche medizinische Wochenschrift (1946), 2007, Jun-08, Volume: 132, Issue:23 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stents; Ticlopidine; Time Factors	2007
Contemporary use of clopidogrel in patients with coronary artery disease. Current cardiology reports, 2007, Volume: 9, Issue:4 Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome	2007
Perioperative use of anti-platelet drugs. Best practice & research. Clinical anaesthesiology, 2007, Volume: 21, Issue:2 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Elective Surgical Procedures; Hemorrhage; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors; Treatment Outcome	2007
[Management coronary syndrome in the acute phase]. Annales de cardiologie et d'angeiologie, 2007, Volume: 56 Suppl 1 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2007
Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI. Minerva cardioangiologica, 2007, Volume: 55, Issue:5 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Evidence-Based Medicine; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Ticlopidine; Treatment Outcome	2007
Aspirin and clopidogrel resistance. Hematology. American Society of Hematology. Education Program, 2007 Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clopidogrel; Coronary Thrombosis; Drug Resistance; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Ticlopidine	2007
[Late coronary stent thrombosis and clopidogrel]. Vnitrni lekarstvi, 2007, Volume: 53, Issue:10 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2007
Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature. Journal of cardiovascular pharmacology and therapeutics, 2007, Volume: 12, Issue:4 Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Cocaine; Cocaine-Related Disorders; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome	2007
[Clopidogrel and statins or once more on the danger of direct transfer of results of experimental studies in clinical practice]. Kardiologiia, 2008, Volume: 48, Issue:2 Topics: Atorvastatin; Clopidogrel; Coronary Thrombosis; Diabetes Mellitus, Type 2; Heptanoic Acids; Humans; Hypercholesterolemia; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine	2008
[Pharmacology of ticlopidine and clopidogrel in comparison with acetylsalicylic acid]. Der Internist, 1997, Volume: 38, Issue:11 Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Coronary Thrombosis; Death, Sudden, Cardiac; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	1997
Beyond aspirin. Harvard heart letter : from Harvard Medical School, 1998, Volume: 8, Issue:10 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine	1998
Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting. Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Hematologic Diseases; Humans; Platelet Aggregation Inhibitors; Premedication; Randomized Controlled Trials as Topic; Stents; Ticlopidine	1999
Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999. Journal of thrombosis and thrombolysis, 1999, Volume: 7, Issue:3 Topics: Anemia, Aplastic; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Health Policy; Hematologic Diseases; Hemorrhage; Humans; Multivariate Analysis; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Premedication; Purpura, Thrombotic Thrombocytopenic; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Stents; Ticlopidine; Treatment Outcome	1999
Future directions in thrombolysis. Clinical cardiology, 1999, Volume: 22, Issue:8 Suppl Topics: Clopidogrel; Coronary Disease; Coronary Thrombosis; Cyclooxygenase 2; Enzyme Inhibitors; Fibrinolytic Agents; Forecasting; Humans; Isoenzymes; Membrane Proteins; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prostaglandin-Endoperoxide Synthases; Thrombolytic Therapy; Ticlopidine	1999
Use of clopidrogel in coronary stenting: what was the question? Journal of the American College of Cardiology, 1999, Volume: 34, Issue:7 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Stents; Ticlopidine; Treatment Outcome	1999
Treatment of unstable angina: the role of platelet inhibitors and anticoagulants. The Journal of invasive cardiology, 1999, Volume: 11, Issue:3 Topics: Abciximab; Angina, Unstable; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Thrombosis; Endothelium, Vascular; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Tirofiban; Tyrosine	1999
Antiplatelet agents in cardiology: the choice of therapy. The Annals of thoracic surgery, 2000, Volume: 70, Issue:2 Suppl Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Ticlopidine	2000
The thienopyridines in coronary artery disease. Current cardiology reports, 1999, Volume: 1, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Ticlopidine	1999
Antiplatelet medications and their indications in preventing and treating coronary thrombosis. Annals of medicine, 2000, Volume: 32, Issue:8 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine	2000
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. Journal of the American College of Cardiology, 2002, Jan-02, Volume: 39, Issue:1 Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Humans; Odds Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Registries; Stents; Ticlopidine	2002
Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment. American heart journal, 2002, Volume: 143, Issue:2 Topics: Angina, Unstable; Aspirin; Clopidogrel; Coronary Thrombosis; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Ticlopidine; Time Factors; Warfarin	2002

Trials

81 trial(s) available for clopidogrel and Coronary Thrombosis

Article	Year
A Genotype-Guided Strategy for Oral P2Y The New England journal of medicine, 2019, 10-24, Volume: 381, Issue:17 Topics: Administration, Oral; Aged; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Female; Genotype; Hemorrhage; Humans; Intention to Treat Analysis; Male; Middle Aged; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Precision Medicine; Purinergic P2Y Receptor Antagonists; Single-Blind Method; ST Elevation Myocardial Infarction; Stents; Ticagrelor	2019
Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy. BMC cardiovascular disorders, 2020, 06-03, Volume: 20, Issue:1 Topics: Clinical Decision-Making; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Humans; Multicenter Studies as Topic; Patient Selection; Percutaneous Coronary Intervention; Pharmacogenomic Testing; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Point-of-Care Testing; Polymorphism, Genetic; Prasugrel Hydrochloride; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Saudi Arabia; ST Elevation Myocardial Infarction; Stents; Ticagrelor; Treatment Outcome	2020
Randomized Comparison of Intensified and Standard P2Y Circulation. Cardiovascular interventions, 2020, Volume: 13, Issue:6 Topics: Administration, Oral; Aged; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Early Termination of Clinical Trials; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Recurrence; Risk Assessment; Risk Factors; Stents; Stroke; Time Factors; Treatment Outcome	2020
Clopidogrel Monotherapy vs. Aspirin Monotherapy Following Short-Term Dual Antiplatelet Therapy in Patients Receiving Everolimus-Eluting Coronary Stent Implantation. Circulation journal : official journal of the Japanese Circulation Society, 2020, 08-25, Volume: 84, Issue:9 Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Everolimus; Female; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Treatment Outcome	2020
Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study. JACC. Cardiovascular interventions, 2017, 05-08, Volume: 10, Issue:9 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proportional Hazards Models; Risk Factors; Stents; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2017
6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel). JACC. Cardiovascular interventions, 2017, 06-26, Volume: 10, Issue:12 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; France; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2017
Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents. Thrombosis and haemostasis, 2017, 10-05, Volume: 117, Issue:10 Topics: Aged; Aspirin; Clinical Decision-Making; Clopidogrel; Coronary Disease; Coronary Thrombosis; Decision Support Techniques; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Prosthesis Design; Reproducibility of Results; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2017
Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease. Thrombosis and haemostasis, 2017, 10-05, Volume: 117, Issue:10 Topics: Adenosine; Aged; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Coronary Thrombosis; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome	2017
Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association, 2017, Nov-03, Volume: 6, Issue:11 Topics: Acute Coronary Syndrome; Aged; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Propensity Score; Proportional Hazards Models; Recurrence; Risk Factors; Smoking; ST Elevation Myocardial Infarction; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2017
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018, 11-01, Volume: 92, Issue:5 Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Thrombosis; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Female; Hemorrhage; Hospital Costs; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Models, Economic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Time Factors; Treatment Outcome; United States	2018
Switching from ticagrelor to clopidogrel in patients with ST-segment elevation myocardial infarction undergoing successful percutaneous coronary intervention in real-world China: Occurrences, reasons, and long-term clinical outcomes. Clinical cardiology, 2018, Volume: 41, Issue:11 Topics: Aged; China; Clopidogrel; Coronary Thrombosis; Drug Costs; Drug Substitution; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Readmission; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Risk Factors; ST Elevation Myocardial Infarction; Stroke; Ticagrelor; Time Factors; Treatment Outcome	2018
Impact of low-dose prasugrel on platelet reactivity and cardiac dysfunction in acute coronary syndrome patients requiring primary drug-eluting stent implantation: A randomized comparative study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2020, Volume: 95, Issue:1 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pharmacogenomic Variants; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Time Factors; Tokyo; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling	2020
Targeting thrombogenicity and inflammation in chronic HIV infection. Science advances, 2019, Volume: 5, Issue:6 Topics: Adult; Anti-Inflammatory Agents; Antiretroviral Therapy, Highly Active; Aspirin; Biomarkers; Blood Platelets; Clopidogrel; Coronary Thrombosis; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Gene Expression; HIV Infections; Humans; Immunity, Innate; Inflammation; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II	2019
Telephone contact to improve adherence to dual antiplatelet therapy after drug-eluting stent implantation. Heart (British Cardiac Society), 2013, Volume: 99, Issue:8 Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Counseling; Drug Prescriptions; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Linear Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Patient Discharge; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Quebec; Self Report; Telephone; Tertiary Care Centers; Ticlopidine; Time Factors; Treatment Outcome	2013
Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes). JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:7 Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Aged; Clopidogrel; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome	2013
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial. Circulation, 2013, Sep-03, Volume: 128, Issue:10 Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Female; Follow-Up Studies; Heart Diseases; Humans; Internationality; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Stents; Ticagrelor; Ticlopidine; Treatment Outcome	2013
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-plate JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:9 Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Design; Republic of Korea; Risk Factors; Stroke; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome	2013
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment JACC. Cardiovascular interventions, 2014, Volume: 7, Issue:1 Topics: Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Hyperplasia; Italy; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Myocardial Infarction; Neointima; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Risk Factors; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome	2014
Clinical implications and correlates of Q waves in patients with ST-elevation myocardial infarction treated with fibrinolysis: observations from the CLARITY-TIMI 28 trial. Clinical cardiology, 2014, Volume: 37, Issue:3 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Creatine Kinase, MB Form; Electrocardiography; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Prognosis; Risk Assessment; Sex Factors; Ticlopidine	2014
Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelor. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2014, Volume: 46, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Coronary Artery Bypass; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prospective Studies; Ticagrelor; Ticlopidine	2014
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type. European heart journal, 2014, Aug-01, Volume: 35, Issue:29 Topics: Aspirin; Blood Vessel Prosthesis; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Prosthesis Failure; Sirolimus; Ticlopidine; Treatment Outcome	2014
High clopidogrel dose in patients with chronic kidney disease having clopidogrel resistance after percutaneous coronary intervention. Angiology, 2015, Volume: 66, Issue:4 Topics: Aged; China; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Resistance; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2015
Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014, Volume: 10, Issue:2 Topics: Aged; Angina, Stable; Aspirin; Belgium; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Risk Factors; Stents; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2014
Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: Importance of case fatality rates and effective treatment durations. American heart journal, 2014, Volume: 168, Issue:5 Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Maintenance Chemotherapy; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Failure; Risk Assessment; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2014
Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]). JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:3 Topics: Adenosine Monophosphate; Aged; Anticoagulants; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Double-Blind Method; Female; Hemorrhage; Hirudins; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recombinant Proteins; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome	2015
Stent Thrombosis and Dual Antiplatelet Therapy Interruption With Everolimus-Eluting Stents: Insights From the Xience V Coronary Stent System Trials. Circulation. Cardiovascular interventions, 2015, Volume: 8, Issue:5 Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Combinations; Drug-Eluting Stents; Everolimus; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Time Factors; Withholding Treatment	2015
Prasugrel in Clopidogrel Nonresponders Undergoing Percutaneous Coronary Intervention: The RECLOSE-3 Study (REsponsiveness to CLOpidogrel and StEnt Thrombosis). JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:12 Topics: Aged; Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Drug Substitution; Female; Historically Controlled Study; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome	2015
The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX. European heart journal, 2016, Apr-07, Volume: 37, Issue:14 Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Female; Femoral Artery; Graft Occlusion, Vascular; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Radial Artery; Stents; Ticlopidine; Treatment Outcome	2016
Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Journal of cardiovascular pharmacology, 2016, Volume: 68, Issue:2 Topics: Adenosine; Aged; Chi-Square Distribution; China; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk Factors; ST Elevation Myocardial Infarction; Stroke; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome	2016
Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODI International journal of cardiology, 2016, Jun-01, Volume: 212 Topics: Aged; Aged, 80 and over; Aspirin; Clinical Decision-Making; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Renal Insufficiency, Chronic; Stents; Ticlopidine; Time Factors; Treatment Outcome	2016
6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial. JACC. Cardiovascular interventions, 2016, 07-25, Volume: 9, Issue:14 Topics: Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Hemorrhage; Humans; Intention to Treat Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Republic of Korea; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2016
Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial. Circulation. Cardiovascular interventions, 2016, Volume: 9, Issue:6 Topics: Adenosine Monophosphate; Aged; Brazil; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Europe; Female; Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; New Zealand; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Factors; Thailand; Ticlopidine; Time Factors; Treatment Outcome; United States	2016
Impact of Sex on 2-Year Clinical Outcomes in Patients Treated With 6-Month or 24-Month Dual-Antiplatelet Therapy Duration: A Pre-Specified Analysis From the PRODIGY Trial. JACC. Cardiovascular interventions, 2016, 09-12, Volume: 9, Issue:17 Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemorrhage; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Neointima; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Stents; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial. JACC. Cardiovascular interventions, 2016, 09-26, Volume: 9, Issue:18 Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Aged; Angina, Stable; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Female; Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2016
Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy). Circulation, 2017, May-02, Volume: 135, Issue:18 Topics: Acute Coronary Syndrome; Aged; Angina, Stable; Aspirin; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Incidence; Intention to Treat Analysis; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2017
Effect of 150-mg vs 300-mg loading doses of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement. Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:8 Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Asian People; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Female; Humans; Japan; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine; Time Factors; Treatment Outcome	2008
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial I Circulation, 2008, Oct-14, Volume: 118, Issue:16 Topics: Administration, Oral; Aged; Clopidogrel; Coronary Thrombosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Thrombolytic Therapy; Ticlopidine; Treatment Outcome	2008
Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes. Thrombosis and haemostasis, 2008, Volume: 100, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Myocardial Infarction; Necrosis; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine	2008
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study. Journal of the American College of Cardiology, 2008, Nov-11, Volume: 52, Issue:20 Topics: Aged; Angioplasty, Balloon, Coronary; Antibiotics, Antineoplastic; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Follow-Up Studies; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Sirolimus; Ticlopidine	2008
Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis. The American journal of cardiology, 2009, Jan-01, Volume: 103, Issue:1 Topics: Acute Disease; Aged; Angina Pectoris; Blood Platelets; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Monitoring, Physiologic; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome	2009
Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. The American journal of cardiology, 2009, Mar-15, Volume: 103, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2009
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual American heart journal, 2009, Volume: 157, Issue:4 Topics: Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Dose-Response Relationship, Drug; Double-Blind Method; Drug-Eluting Stents; Follow-Up Studies; Humans; Incidence; Myocardial Revascularization; Platelet Aggregation Inhibitors; Postoperative Care; Survival Rate; Ticlopidine; Time Factors; Treatment Outcome	2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Sho Circulation, 2009, Jun-30, Volume: 119, Issue:25 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Blood Platelets; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Thrombosis; Double-Blind Method; Drug Resistance; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Tirofiban; Tyrosine	2009
Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction. Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Emergency Medical Services; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Thrombolytic Therapy; Ticlopidine; Tirofiban; Tyrosine	2009
Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. The American journal of cardiology, 2009, Nov-15, Volume: 104, Issue:10 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Sirolimus; Ticlopidine	2009
Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes. Basic research in cardiology, 2010, Volume: 105, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Leukocytes; Male; Obesity; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Stents; Ticlopidine	2010
Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. British journal of anaesthesia, 2010, Volume: 104, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Loss, Surgical; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug-Eluting Stents; Emergencies; Female; Hemostasis, Surgical; Humans; Male; Middle Aged; Perioperative Care; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Substance Withdrawal Syndrome; Ticlopidine; Tirofiban; Tyrosine	2010
High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patients. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Resistance; Drug-Eluting Stents; Female; Follow-Up Studies; France; Hemorrhage; Hospitals, University; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Regression Analysis; Risk; Stents; Ticlopidine; Treatment Outcome	2010
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation, 2010, Nov-23, Volume: 122, Issue:21 Topics: Acute Coronary Syndrome; Adenosine; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Electrocardiography; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk Factors; Ticagrelor; Ticlopidine; Treatment Outcome	2010
A case-control study on platelet reactivity in patients with coronary stent thrombosis. Journal of thrombosis and haemostasis : JTH, 2011, Volume: 9, Issue:5 Topics: Aged; Aspirin; Blood Platelets; Case-Control Studies; Clopidogrel; Coronary Thrombosis; Female; Flow Cytometry; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine; Treatment Outcome; Vasodilator Agents	2011
Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation, 2011, Apr-26, Volume: 123, Issue:16 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heparin; Hirudins; Humans; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Peptide Fragments; Platelet Aggregation Inhibitors; Predictive Value of Tests; Recombinant Proteins; Risk Factors; Ticlopidine; Treatment Outcome; Tubulin Modulators	2011
Residual platelet reactivity after clopidogrel loading in patients with ST-elevation myocardial infarction undergoing an unexpectedly delayed primary percutaneous coronary intervention. - Impact on intracoronary thrombus burden and myocardial perfusion-. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:9 Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Circulation; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors	2011
Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study. American heart journal, 2011, Volume: 162, Issue:2 Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Prosthesis Failure; Receptors, Purinergic P2Y12; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome	2011
A novel regimen of alternate day clopidogrel would provide a cost-effective strategy to prevent very late stent thrombosis. Medical hypotheses, 2012, Volume: 78, Issue:1 Topics: Aspirin; Clopidogrel; Cohort Studies; Coronary Thrombosis; Drug-Eluting Stents; Equipment Safety; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2012
The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, May-01, Volume: 79, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Emergency Medical Services; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Prospective Studies; Severity of Illness Index; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Vascular Patency	2012
Effects of pantoprazole on dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention. Pharmacological reports : PR, 2012, Volume: 64, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Angina, Stable; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Stents; Ticlopidine; Treatment Outcome	2012
Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study. Journal of the American College of Cardiology, 2012, Jul-17, Volume: 60, Issue:3 Topics: Acute Coronary Syndrome; Adenosine; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Cross-Over Studies; Female; Humans; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine	2012
Angiographic and platelet reactivity outcomes with prasugrel 60 mg pretreatment and clopidogrel 600 mg pretreatment in primary percutaneous coronary intervention. Journal of thrombosis and thrombolysis, 2012, Volume: 34, Issue:4 Topics: Adult; Aged; Asian People; Clopidogrel; Cohort Studies; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Preoperative Care; Singapore; Thiophenes; Ticlopidine	2012
Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention. European journal of clinical pharmacology, 2013, Volume: 69, Issue:4 Topics: Adolescent; Adult; Aged; Aryl Hydrocarbon Hydroxylases; Asian People; China; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; DNA; Female; Genotype; Heart Diseases; Humans; Linear Models; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Stents; Ticlopidine; Young Adult	2013
Bedside monitoring to adjust antiplatelet therapy for coronary stenting. The New England journal of medicine, 2012, Nov-29, Volume: 367, Issue:22 Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Monitoring; Female; Humans; Male; Middle Aged; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prasugrel Hydrochloride; Pyridines; Retreatment; Stents; Thiophenes; Ticlopidine	2012
Efficacy and safety of low-dose clopidogrel in Japanese patients after drug-eluting stent implantation: a randomized pilot trial. Heart and vessels, 2014, Volume: 29, Issue:1 Topics: Aged; Asian People; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Japan; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Pilot Projects; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2014
Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel. American heart journal, 2013, Volume: 165, Issue:2 Topics: Administration, Oral; Adult; Aspirin; Clopidogrel; Coronary Thrombosis; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Follow-Up Studies; Gastrointestinal Diseases; Humans; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Tablets, Enteric-Coated; Ticlopidine; Treatment Outcome	2013
Sustained platelet activation following intracoronary beta irradiation. The American journal of cardiology, 2002, Dec-15, Volume: 90, Issue:12 Topics: Angioplasty, Balloon, Coronary; Beta Particles; Blood Platelets; Brachytherapy; CD40 Ligand; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoprotein IIb; Prospective Studies; Stents; Strontium Radioisotopes; Ticlopidine; Yttrium Radioisotopes	2002
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation, 2004, Mar-16, Volume: 109, Issue:10 Topics: Aged; Anticoagulants; Aspirin; Catheterization; Clopidogrel; Combined Modality Therapy; Comorbidity; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Death, Sudden; Diabetes Mellitus; Disease-Free Survival; Drug Implants; Female; Follow-Up Studies; Humans; Life Tables; Male; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Safety; Sirolimus; Stents; Survival Analysis; Ticlopidine; Treatment Outcome	2004
Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting. Thrombosis research, 2003, Volume: 112, Issue:1-2 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; beta-Thromboglobulin; Blood Vessel Prosthesis; Clopidogrel; Coronary Thrombosis; Double-Blind Method; Humans; Male; Middle Aged; Platelet Activation; Stents; Ticlopidine	2003
Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study. Circulation, 2005, Mar-08, Volume: 111, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Eptifibatide; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Necrosis; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Risk Factors; Stents; Ticlopidine	2005
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis. Journal of the American College of Cardiology, 2005, Mar-15, Volume: 45, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2005
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial. Circulation, 2005, Dec-20, Volume: 112, Issue:25 Topics: Adolescent; Adult; Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Secondary Prevention; Ticlopidine; Treatment Outcome; Vascular Patency	2005
Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy. European heart journal, 2006, Volume: 27, Issue:17 Topics: Adolescent; Adult; Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Double-Blind Method; Drug Combinations; Fibrinolytic Agents; Humans; Microcirculation; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Ticlopidine	2006
[Prevention of atherothrombotic incidents. CHARISMA Study (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance]. Der Internist, 2006, Volume: 47, Issue:12 Topics: Aged; Aspirin; Cause of Death; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Embolism, Cholesterol; Female; Humans; Intracranial Embolism; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine	2006
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. Journal of the American College of Cardiology, 2006, Dec-19, Volume: 48, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine	2006
Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent. The American journal of cardiology, 2007, Apr-15, Volume: 99, Issue:8 Topics: Aspirin; Carbon; Cause of Death; Clopidogrel; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Combinations; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Prospective Studies; Reoperation; Stents; Ticlopidine; Treatment Outcome	2007
TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. European heart journal, 2007, Volume: 28, Issue:21 Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Epidemiologic Methods; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Polymers; Ticlopidine	2007
Clopidogrel 600-mg double loading dose achieves stronger platelet inhibition than conventional regimens: results from the PREPAIR randomized study. Journal of the American College of Cardiology, 2008, Mar-18, Volume: 51, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2008
Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation, 1999, May-11, Volume: 99, Issue:18 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Diarrhea; Drug Eruptions; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Neutropenia; Platelet Aggregation Inhibitors; Postoperative Complications; Safety; Stents; Ticlopidine; Treatment Outcome	1999
Clopidogrel as adjunctive antiplatelet therapy during coronary stenting. Journal of the American College of Cardiology, 1999, Volume: 34, Issue:7 Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Safety; Stents; Ticlopidine; Treatment Outcome	1999
Clopidogrel versus ticlopidine after intracoronary stent placement. Journal of the American College of Cardiology, 1999, Volume: 34, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Safety; Secondary Prevention; Stents; Ticlopidine; Time Factors; Treatment Outcome	1999
[Acute coronary syndrome, stent and cardiac insufficiency. Advances in thrombosis prevention]. Der Internist, 1999, Volume: 40, Issue:12 Suppl F Topics: Acute Disease; Clopidogrel; Coronary Disease; Coronary Thrombosis; Coumarins; Humans; Platelet Aggregation Inhibitors; Ticlopidine	1999
A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation, 2000, Feb-15, Volume: 101, Issue:6 Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Treatment Outcome	2000
Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart (British Cardiac Society), 2001, Volume: 85, Issue:1 Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Humans; Platelet Activation; Platelet Aggregation; Stents; Ticlopidine	2001
Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation, 2001, Jul-31, Volume: 104, Issue:5 Topics: Abciximab; Antibodies, Monoclonal; Clopidogrel; Coronary Disease; Coronary Thrombosis; Eptifibatide; Exanthema; Female; Gastrointestinal Diseases; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Neutropenia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Thrombocytopenia; Ticlopidine; Tirofiban; Tyrosine	2001

Other Studies

299 other study(ies) available for clopidogrel and Coronary Thrombosis

Article	Year
Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study. Pediatric rheumatology online journal, 2022, Dec-05, Volume: 20, Issue:1 Topics: Aspirin; Child; Clopidogrel; Coronary Aneurysm; Coronary Thrombosis; Fibrinolytic Agents; Heparin; Humans; Male; Mucocutaneous Lymph Node Syndrome; Quality of Life; Tissue Plasminogen Activator; Warfarin	2022
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. European heart journal. Cardiovascular pharmacotherapy, 2020, 07-01, Volume: 6, Issue:4 Topics: Aged; Brain Ischemia; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Decision Support Techniques; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Pharmacogenomic Variants; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Predictive Value of Tests; Risk Assessment; Risk Factors; Stents; Stroke; Treatment Outcome	2020
Clinical outcomes after ticagrelor and clopidogrel in Chinese post-stented patients. Atherosclerosis, 2019, Volume: 290 Topics: Acute Coronary Syndrome; Aged; Asian People; China; Clopidogrel; Coronary Thrombosis; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk Assessment; Risk Factors; Stents; Ticagrelor; Time Factors; Treatment Outcome	2019
Dual Antiplatelet Therapy Increases Hemorrhagic Transformation Following Thrombolytic Treatment in Experimental Stroke. Stroke, 2019, Volume: 50, Issue:12 Topics: Animals; Aspirin; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Drug Therapy, Combination; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Male; Mice; Platelet Aggregation Inhibitors; Platelet Function Tests; Secondary Prevention; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator	2019
Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan. European heart journal. Cardiovascular pharmacotherapy, 2020, 07-01, Volume: 6, Issue:4 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Clopidogrel; Coronary Thrombosis; Databases, Factual; Female; Hemorrhage; Hospital Mortality; Hospitalization; Humans; Incidence; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Propensity Score; Prospective Studies; Registries; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome	2020
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention. Cardiovascular diabetology, 2019, 11-09, Volume: 18, Issue:1 Topics: Aged; Biomarkers; Blood Glucose; Blood Platelets; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Treatment Outcome	2019
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2020, 10-01, Volume: 96, Issue:4 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Female; Germany; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Registries; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2020
Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention. Journal of cardiovascular translational research, 2020, Volume: 13, Issue:4 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus; Drug Resistance; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome	2020
MAPT (Mono Antiplatelet Therapy) as Regular Regimen After COBRA PzF™ NanoCoated Coronary Stent (NCS) Implantation. Cardiovascular revascularization medicine : including molecular interventions, 2020, Volume: 21, Issue:6 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chromium Alloys; Clopidogrel; Coated Materials, Biocompatible; Coronary Artery Disease; Coronary Thrombosis; Female; Hemorrhage; Humans; Male; Organophosphorus Compounds; Platelet Aggregation Inhibitors; Polymers; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Stents; Time Factors; Treatment Outcome	2020
Derivation, Validation, and Prognostic Utility of a Prediction Rule for Nonresponse to Clopidogrel: The ABCD-GENE Score. JACC. Cardiovascular interventions, 2020, 03-09, Volume: 13, Issue:5 Topics: Age Factors; Aged; Body Mass Index; Clinical Decision Rules; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Databases, Factual; Diabetes Mellitus; Drug Resistance; Female; Humans; Male; Middle Aged; Myocardial Infarction; Obesity; Percutaneous Coronary Intervention; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Reproducibility of Results; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2020
Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI: Results of the GIANT Study. JACC. Cardiovascular interventions, 2020, 03-09, Volume: 13, Issue:5 Topics: Aged; Clinical Decision-Making; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Resistance; Female; France; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prasugrel Hydrochloride; Precision Medicine; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome	2020
Reloading When Switching From Ticagrelor or Prasugrel to Clopidogrel Within 7 Days After STEMI. JACC. Cardiovascular interventions, 2020, 03-09, Volume: 13, Issue:5 Topics: Clinical Decision-Making; Clopidogrel; Coronary Thrombosis; Drug Substitution; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction; Ticagrelor; Time Factors; Treatment Outcome	2020
Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention. Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:2 Topics: Aged; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Ticagrelor; Time Factors; Treatment Outcome	2020
Ticagrelor Versus Clopidogrel in Patients with Late or Very Late Stent Thrombosis. Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:5 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Ticagrelor; Time Factors; Treatment Outcome	2020
Comparison Between Clopidogrel and Prasugrel Associated With CYP2C19 Genotypes in Patients Receiving Percutaneous Coronary Intervention in a Japanese Population. Circulation journal : official journal of the Japanese Circulation Society, 2020, 08-25, Volume: 84, Issue:9 Topics: Aged; Aged, 80 and over; Alleles; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Genotype; Hemorrhage; Humans; Japan; Loss of Function Mutation; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; Stroke; Treatment Outcome	2020
Potentially increased incidence of scaffold thrombosis in patients treated with Absorb BVS who terminated DAPT before 18 months. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2017, Jun-02, Volume: 13, Issue:2 Topics: Absorbable Implants; Aged; Aspirin; Cardiovascular Agents; Clopidogrel; Coated Materials, Biocompatible; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Netherlands; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Registries; Retrospective Studies; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2017
Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome. Clinical cardiology, 2017, Volume: 40, Issue:10 Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Computer Simulation; Coronary Thrombosis; Cost-Benefit Analysis; Decision Trees; Disease-Free Survival; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Middle Aged; Models, Economic; Monte Carlo Method; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2017
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. JACC. Cardiovascular interventions, 2017, 10-23, Volume: 10, Issue:20 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Databases, Factual; Hemorrhage; Humans; Kaplan-Meier Estimate; Kidney; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Propensity Score; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome; United States	2017
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. JACC. Cardiovascular interventions, 2017, 08-28, Volume: 10, Issue:16 Topics: Aged; Aspirin; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Germany; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Proportional Hazards Models; Prospective Studies; Registries; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; United States	2017
Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2018, 03-20, Volume: 13, Issue:16 Topics: Anticoagulants; Clopidogrel; Coronary Thrombosis; Hemorrhage; Humans; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome	2018
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study. The Canadian journal of cardiology, 2018, Volume: 34, Issue:3 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Clopidogrel; Cohort Studies; Combined Modality Therapy; Coronary Thrombosis; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Analysis; Ticlopidine; Treatment Outcome; United States	2018
Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry. Thrombosis and haemostasis, 2018, Volume: 118, Issue:5 Topics: Aged; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Administration Schedule; Drug Substitution; Drug-Eluting Stents; Female; Hemorrhage; Humans; Italy; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Registries; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome	2018
Predictors of coronary stent thrombosis: a case-control study. Journal of thrombosis and thrombolysis, 2018, Volume: 46, Issue:3 Topics: Aged; Aspirin; Brazil; Case-Control Studies; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prognosis; Prosthesis Design; Risk Factors; Stents	2018
Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk. Clinical and experimental medicine, 2018, Volume: 18, Issue:4 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Colitis, Ulcerative; Coronary Thrombosis; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticagrelor	2018
External Validation of the DAPT Score in a Nationwide Population. Journal of the American College of Cardiology, 2018, 09-04, Volume: 72, Issue:10 Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Decision Support Techniques; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Assessment; Stents; Stroke; Sweden	2018
Prasugrel versus clopidogrel for residual thrombus burden in patients with ST-segment elevation myocardial infarction: an optical coherence tomography study. Coronary artery disease, 2018, Volume: 29, Issue:8 Topics: Aged; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Predictive Value of Tests; Retrospective Studies; ST Elevation Myocardial Infarction; Stents; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2018
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Circulation. Cardiovascular interventions, 2018, Volume: 11, Issue:10 Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Decision Support Techniques; Drug Therapy, Combination; Drug-Eluting Stents; Female; Germany; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Registries; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States	2018
Clopidogrel pharmacogenetics: associations between genotype and stent thrombosis risk in patients with stent placement. Journal of cardiovascular medicine (Hagerstown, Md.), 2019, Volume: 20, Issue:1 Topics: Aged; ATP Binding Cassette Transporter, Subfamily B; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Pilot Projects; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors; Stents	2019
Intravenous Antiplatelet Therapy Bridging in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention. Cardiovascular revascularization medicine : including molecular interventions, 2019, Volume: 20, Issue:9 Topics: Adenosine Monophosphate; Administration, Intravenous; Aged; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Perioperative Care; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Time Factors; Tirofiban; Treatment Outcome	2019
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk. Circulation. Cardiovascular quality and outcomes, 2019, Volume: 12, Issue:1 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Clinical Decision-Making; Clopidogrel; Coronary Thrombosis; Cost Savings; Cost-Benefit Analysis; Drug Costs; Drug-Eluting Stents; Europe; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Registries; Risk Assessment; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; United States	2019
Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention. Cardiovascular research, 2019, 08-01, Volume: 115, Issue:10 Topics: Aged; Aged, 80 and over; Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Resistance; Europe; Female; Genetic Association Studies; Genetic Predisposition to Disease; Hemorrhage; Homozygote; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Soluble Guanylyl Cyclase; Stents; Time Factors; Treatment Outcome	2019
Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y Circulation. Cardiovascular interventions, 2019, Volume: 12, Issue:3 Topics: Adenosine Monophosphate; Aged; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Stents; Time Factors; Treatment Outcome	2019
Long-term outcome after angiographically proven coronary stent thrombosis. The American journal of cardiology, 2013, May-01, Volume: 111, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Female; Follow-Up Studies; Germany; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Prosthesis Failure; Registries; Retrospective Studies; Risk Factors; Shock, Cardiogenic; Ticlopidine; Time Factors; Treatment Outcome	2013
Safety and efficacy of intense antithrombotic treatment and percutaneous coronary intervention deferral in patients with large intracoronary thrombus. The American journal of cardiology, 2013, Jun-15, Volume: 111, Issue:12 Topics: Acute Coronary Syndrome; Angiography; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Cohort Studies; Coronary Thrombosis; Enoxaparin; Humans; Inpatients; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Thrombectomy; Thrombolytic Therapy; Ticlopidine	2013
Thrombocytosis as a potential cause of a very late stent thrombosis in the left main coronary artery. Kardiologia polska, 2013, Volume: 71, Issue:3 Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Out-of-Hospital Cardiac Arrest; Paclitaxel; Thrombocytosis; Ticlopidine; Withholding Treatment	2013
Antiplatelet therapy. Cangrelor succeeds, at last, in PCI. Nature reviews. Cardiology, 2013, Volume: 10, Issue:6 Topics: Adenosine Monophosphate; Administration, Intravenous; Administration, Oral; Blood Platelets; Clopidogrel; Coronary Thrombosis; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticlopidine; Treatment Outcome	2013
Relationship between aspirin/clopidogrel resistance and intra-stent thrombi assessed by follow-up optical coherence tomography after drug-eluting stent implantation. European heart journal. Cardiovascular Imaging, 2013, Volume: 14, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Cohort Studies; Confidence Intervals; Coronary Angiography; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Platelet Aggregation Inhibitors; Prosthesis Failure; Retrospective Studies; Risk Assessment; Severity of Illness Index; Thrombosis; Ticlopidine; Tomography, Optical Coherence; Treatment Outcome	2013
Abciximab bolus with optional infusion in intervention for ST-elevation myocardial infarction. Scandinavian cardiovascular journal : SCJ, 2013, Volume: 47, Issue:4 Topics: Abciximab; Aged; Aged, 80 and over; Antibodies, Monoclonal; Clopidogrel; Coronary Thrombosis; Cost Savings; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Infusions, Parenteral; Injections; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recurrence; Registries; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2013
[Relevance of CYP2C19 2 regarding platelet reactivity in patients with acute coronary syndrome treated with clopidogrel]. Medicina clinica, 2014, Jul-07, Volume: 143, Issue:1 Topics: Acute Coronary Syndrome; Aged; Alleles; Angina, Unstable; Aryldialkylphosphatase; Biotransformation; Cardiac Catheterization; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Genotype; Hospital Mortality; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prognosis; Prospective Studies; Purinergic P2Y Receptor Antagonists; Risk Factors; Stents; Stroke; Survival Analysis; Ticlopidine	2014
P2Y12 Receptor Blockade and Myocardial Perfusion. JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:7 Topics: Acute Coronary Syndrome; Adenosine; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Ticlopidine	2013
The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2013, Volume: 9, Issue:3 Topics: Acute Coronary Syndrome; Aged; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Ischemia; China; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Resistance; Drug-Eluting Stents; Female; Genotype; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prospective Studies; Receptors, Purinergic P2Y12; Risk Factors; ROC Curve; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2013
Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs). JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:8 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Cell Adhesion Molecules; Clopidogrel; Coronary Thrombosis; Drug Resistance; Female; Hemorrhage; Humans; Logistic Models; Male; Microfilament Proteins; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Phosphoproteins; Phosphorylation; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve; Thiophenes; Ticlopidine; Time Factors; Treatment Outcome	2013
Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation. Heart and vessels, 2014, Volume: 29, Issue:5 Topics: Aged; Anticoagulants; Asian People; Aspirin; Atrial Fibrillation; Blood Coagulation; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Disease-Free Survival; Drug Monitoring; Drug Therapy, Combination; Female; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors; Stents; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin	2014
[The CHAMPION PHOENIX study]. Giornale italiano di cardiologia (2006), 2013, Volume: 14, Issue:10 Topics: Adenosine Monophosphate; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Double-Blind Method; Hemorrhage; Humans; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Stents; Ticlopidine	2013
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC. Cardiovascular interventions, 2013, Volume: 6, Issue:11 Topics: Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; Biotransformation; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Decision Support Techniques; Drug Therapy, Combination; Drug-Eluting Stents; Female; Genotype; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Patient Selection; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2013
Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: an in vitro pharmacodynamic investigation. Journal of cardiovascular translational research, 2014, Volume: 7, Issue:1 Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Hypothermia, Induced; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Receptors, Purinergic P2Y12; Risk Factors; Ticlopidine; Treatment Outcome	2014
Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndrome. International journal of cardiology, 2014, Mar-01, Volume: 172, Issue:1 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine	2014
A cautionary tale on the use of antiplatelet treatment following TURP. BMJ case reports, 2014, Apr-04, Volume: 2014 Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Hematuria; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombosis; Ticlopidine; Transurethral Resection of Prostate; Urinary Bladder; Urinary Bladder Diseases	2014
A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry. Thrombosis and haemostasis, 2014, Volume: 112, Issue:2 Topics: Aged; Aged, 80 and over; Blood Platelets; Case-Control Studies; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug Substitution; Female; Germany; Hemorrhage; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Precision Medicine; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Registries; Risk Factors; Thiophenes; Ticlopidine; Time Factors; Treatment Outcome	2014
Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Annals of internal medicine, 2014, Feb-18, Volume: 160, Issue:4 Topics: Acute Coronary Syndrome; Adenosine; Alleles; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Coronary Thrombosis; Cost-Benefit Analysis; Cytochrome P-450 CYP2C19; Decision Support Techniques; Direct Service Costs; Drug Therapy, Combination; Drugs, Generic; Genotype; Hemorrhage; Humans; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prasugrel Hydrochloride; Quality-Adjusted Life Years; Risk Factors; Thiophenes; Ticagrelor; Ticlopidine	2014
Subacute bioresorbable vascular scaffold thrombosis: a report of 2 cases. Heart and vessels, 2015, Volume: 30, Issue:4 Topics: Absorbable Implants; Adenosine; Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Treatment Outcome	2015
Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY). Archives of cardiovascular diseases, 2014, Volume: 107, Issue:4 Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Female; France; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prospective Studies; Registries; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2014
Fixed combination dual antiplatelet therapy and the risk of stent thrombosis. International journal of cardiology, 2014, Jun-15, Volume: 174, Issue:2 Topics: Aged, 80 and over; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Medication Adherence; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine	2014
Acute coronary thrombosis and multiple coronary aneurysms in a 22-year-old man with the human immunodeficiency virus. Texas Heart Institute journal, 2014, Volume: 41, Issue:2 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Aneurysm; Coronary Angiography; Coronary Thrombosis; Electrocardiography; HIV; HIV Infections; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome; Young Adult	2014
An atypical presentation of an extremely late stent thrombosis after more than 7 years (2634 days) of DES implantation in a patient without obvious risk factors on regular dual antiplatelet therapy. BMJ case reports, 2014, Jul-15, Volume: 2014 Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Ticlopidine; Time Factors	2014
Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study. BMC cardiovascular disorders, 2014, Aug-13, Volume: 14 Topics: Aged; Clopidogrel; Coronary Thrombosis; Denmark; Drug Administration Schedule; Drug Prescriptions; Drug-Eluting Stents; Female; Humans; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2014
Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry. Thrombosis and haemostasis, 2014, Volume: 112, Issue:6 Topics: Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Coronary Thrombosis; Female; Germany; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Recurrence; Registries; Risk Factors; Shock, Cardiogenic; Thiophenes; Ticlopidine; Time Factors; Treatment Outcome	2014
Changes in thrombus composition and profilin-1 release in acute myocardial infarction. European heart journal, 2015, Apr-21, Volume: 36, Issue:16 Topics: Analysis of Variance; Blood Platelets; Clopidogrel; Coronary Thrombosis; Female; Fibrinogen; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Profilins; Thrombectomy; Thrombin; Ticlopidine; Time-to-Treatment	2015
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study. JACC. Cardiovascular interventions, 2014, Volume: 7, Issue:10 Topics: Acute Coronary Syndrome; Aged; Biotransformation; Blood Platelets; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Female; Genotype; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Phenotype; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2014
Optimising pharmacotherapy for secondary prevention of non-invasively managed acute coronary syndrome. The Medical journal of Australia, 2014, Nov-17, Volume: 201, Issue:10 Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Thrombosis; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Ticlopidine	2014
Tailored antiplatelet therapy in a patient with ITP and clopidogrel resistance. Thrombosis and haemostasis, 2015, Volume: 113, Issue:3 Topics: Adenosine; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug Substitution; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Purpura, Thrombocytopenic, Idiopathic; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome	2015
Intrastent thrombus – what you see is what you get? Circulation journal : official journal of the Japanese Circulation Society, 2015, Volume: 79, Issue:1 Topics: Angioscopy; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Humans; Male; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Ticlopidine	2015
Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients with acute myocardial infarction. International journal of cardiology, 2015, Mar-15, Volume: 183 Topics: Absorbable Implants; Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Everolimus; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Ticlopidine; Treatment Outcome	2015
Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy. JACC. Cardiovascular interventions, 2015, Volume: 8, Issue:3 Topics: Aged; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Prosthesis Design; Registries; Risk Factors; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2015
Plasma fibrin clot phenotype independently affects intracoronary thrombus ultrastructure in patients with acute myocardial infarction. Thrombosis and haemostasis, 2015, Volume: 113, Issue:6 Topics: Aged; Aspirin; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Erythrocytes; Female; Fibrin; Fibrinolysis; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Permeability; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Porosity; Suction; Thrombectomy; Ticlopidine; Time Factors	2015
Characterization of patients with angioscopically-detected in-stent mural thrombi – genetics of clopidogrel responsiveness and generations of drug-eluting stents. Circulation journal : official journal of the Japanese Circulation Society, 2015, Volume: 79, Issue:1 Topics: Activation, Metabolic; Aged; Alleles; Angina Pectoris; Angioscopy; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Receptors, Purinergic P2Y12; Ticlopidine	2015
Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies. Journal of cardiovascular pharmacology and therapeutics, 2015, Volume: 20, Issue:6 Topics: Adenosine; Adult; Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Coagulation; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Rivaroxaban; Thrombin; Ticagrelor; Ticlopidine	2015
Cardioembolic acute myocardial infarction associated with apical ballooning: Considerations. International journal of cardiology, 2015, Aug-01, Volume: 192 Topics: Aged, 80 and over; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Echocardiography; Electrocardiography; Enoxaparin; Female; Humans; Myocardial Infarction; Takotsubo Cardiomyopathy; Ticlopidine	2015
Very late bioresorbable vascular scaffold thrombosis: a new clinical entity. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015, May-19, Volume: 11, Issue:1 Topics: Absorbable Implants; Aged, 80 and over; Anterior Wall Myocardial Infarction; Brachytherapy; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Metals; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis Design; Severity of Illness Index; Stents; Ticlopidine; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2015
Cytochrome P450 CYP 2C192 Associated with Adverse 1-Year Cardiovascular Events in Patients with Acute Coronary Syndrome. PloS one, 2015, Volume: 10, Issue:7* Topics: Activation, Metabolic; Acute Coronary Syndrome; Aged; Alleles; Angina Pectoris; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Prodrugs; Prognosis; Prospective Studies; Recurrence; Stents; Ticlopidine; Treatment Outcome	2015
Successful Prasugrel Therapy for Recurrent Left Main Stent Thrombosis in a Clopidogrel Hyporesponder. Texas Heart Institute journal, 2015, Volume: 42, Issue:5 Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prosthesis Design; Recurrence; Ticlopidine; Time Factors; Treatment Outcome	2015
Very late scaffold thrombosis of everolimus-eluting bioresorbable scaffold following implantation in STEMI after discontinuation of dual antiplatelet therapy. Cardiovascular intervention and therapeutics, 2017, Volume: 32, Issue:1 Topics: Absorbable Implants; Adult; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Design; ST Elevation Myocardial Infarction; Ticlopidine; Tissue Scaffolds; Withholding Treatment	2017
Impact of Cytochrome P450 2C192 and 3 on Clopidogrel Loading Dose in Saudi Patients with Acute Coronary Syndrome. Drug metabolism letters, 2016, Volume: 10, Issue:1 Topics: Acute Coronary Syndrome; Aged; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Dosage Calculations; Female; Genotype; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation Inhibitors; Platelet Function Tests; Polymorphism, Genetic; Prospective Studies; Saudi Arabia; Sex Factors; Ticlopidine; Treatment Outcome	2016
Stent thrombosis after primary percutaneous coronary intervention in comatose survivors of out-of-hospital cardiac arrest: Are the new P2Y12 inhibitors really more effective than clopidogrel? Resuscitation, 2016, Volume: 98 Topics: Adenosine; Aspirin; Clopidogrel; Coma; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; Risk Factors; Stents; Ticagrelor; Ticlopidine; Treatment Outcome	2016
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents). JACC. Cardiovascular interventions, 2015, Dec-28, Volume: 8, Issue:15 Topics: Aged; Aspirin; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Germany; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Registries; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; United States	2015
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. Journal of the American College of Cardiology, 2016, May-17, Volume: 67, Issue:19 Topics: Acute Coronary Syndrome; Age Factors; Aged; Anemia; Aspirin; Body Mass Index; Clopidogrel; Cohort Studies; Coronary Thrombosis; Diabetes Mellitus; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Medication Adherence; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Renal Insufficiency; Risk Assessment; Smoking; Ticlopidine; United States	2016
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study. JACC. Cardiovascular interventions, 2016, 07-25, Volume: 9, Issue:14 Topics: Aged; Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Germany; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome; United States	2016
Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. The Journal of urology, 2017, Volume: 197, Issue:1 Topics: Age Factors; Aged; Aspirin; Blood Loss, Surgical; Blood Transfusion; Carcinoma, Renal Cell; Clopidogrel; Coronary Thrombosis; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Patient Readmission; Perioperative Period; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Retrospective Studies; Risk Factors; Treatment Outcome	2017
CASE 11-2016 Perioperative Coronary Thrombosis in a Patient With Multiple Second-Generation Drug-Eluting Stents: Is It Time for a Paradigm Shift? Journal of cardiothoracic and vascular anesthesia, 2016, Volume: 30, Issue:6 Topics: Analgesics, Opioid; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Metoprolol; Middle Aged; Morphine; Myocardial Infarction; Nitroglycerin; Ovarian Neoplasms; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Retreatment; Ticlopidine; Treatment Outcome; Vasodilator Agents	2016
Increased Platelet-leukocyte Aggregates Are Associated With Myocardial No-reflow in Patients With ST Elevation Myocardial Infarction. The American journal of the medical sciences, 2016, Volume: 352, Issue:3 Topics: Aspirin; Blood Platelets; Clopidogrel; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Electrocardiography; Female; Flow Cytometry; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Predictive Value of Tests; Retrospective Studies; Ticlopidine	2016
Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017, Jun-01, Volume: 89, Issue:7 Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Drug Antagonism; Drug Therapy, Combination; Europe; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Proton Pump Inhibitors; Registries; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome; United States	2017
Platelet aggregation and the risk of stent thrombosis or bleeding in elective percutaneous coronary intervention patients. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2017, Volume: 28, Issue:5 Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Thrombosis; Elective Surgical Procedures; Female; Hemorrhage; Humans; Male; Middle Aged; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Risk Factors; Stents; Ticlopidine	2017
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention. Circulation. Cardiovascular interventions, 2017, Volume: 10, Issue:1 Topics: Adenosine Monophosphate; Aged; Brain Ischemia; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2017
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). Circulation. Cardiovascular interventions, 2017, Volume: 10, Issue:2 Topics: Aged; Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Germany; Hemorrhage; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Propensity Score; Prospective Studies; Purinergic P2Y Receptor Antagonists; Registries; Risk Factors; Sex Factors; Ticlopidine; Time Factors; Treatment Outcome; United States	2017
Out-of-hospital cardiac arrest and stent thrombosis: Ticagrelor versus clopidogrel in patients with primary percutaneous coronary intervention under mild therapeutic hypothermia. Resuscitation, 2017, Volume: 114 Topics: Adenosine; Aged; Clopidogrel; Coronary Thrombosis; Humans; Hypothermia, Induced; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stents; Ticagrelor; Ticlopidine	2017
Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). Circulation. Cardiovascular interventions, 2017, Volume: 10, Issue:3 Topics: Aged; Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Peripheral Arterial Disease; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Prospective Studies; Purinergic P2Y Receptor Antagonists; Registries; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2017
Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance. Journal of Korean medical science, 2008, Volume: 23, Issue:3 Topics: Aged; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Electrocardiography; Female; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors	2008
Efficient tirofiban infusion resulting in resolution of intracoronary thrombus. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2008, Volume: 36, Issue:3 Topics: Anticholesteremic Agents; Aspirin; Atorvastatin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Fibrinolytic Agents; Heptanoic Acids; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyrroles; Ticlopidine; Tirofiban; Tyrosine	2008
Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis? Clinical research in cardiology : official journal of the German Cardiac Society, 2008, Volume: 97, Issue:11 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Right	2008
Very late stent thrombosis after discontinuation of clopidogrel therapy. The Medical journal of Australia, 2008, Aug-18, Volume: 189, Issue:4 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Failure; Radiography; Stents; Ticlopidine; Time Factors	2008
Safety and efficacy of low-dose clopidogrel in Japanese patients undergoing coronary stenting: preliminary 30-day clinical outcome. Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:10 Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Safety; Stents; Ticlopidine; Treatment Outcome	2008
Clopidogrel in a pediatric population: prescribing practice and outcomes from a single center. Pediatric cardiology, 2009, Volume: 30, Issue:2 Topics: Adolescent; Child; Child Welfare; Child, Preschool; Clopidogrel; Coronary Thrombosis; Drug Prescriptions; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Male; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies; Ticlopidine; Treatment Outcome	2009
What to do with patients receiving long-term clopidogrel: reload or relax? Circulation, 2008, Sep-16, Volume: 118, Issue:12 Topics: Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Humans; Platelet Aggregation; Randomized Controlled Trials as Topic; Relaxation; Ticlopidine; Time	2008
[Severe myocardial infarction due to late and very late stent thrombosis after coronary artery stenting with drug-eluting stents]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:40 Topics: Aged; Aspirin; Cardiac Catheterization; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Creatine Kinase; Drug-Eluting Stents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine	2008
Identifying clopidogrel resistance during chronic therapy: the case for a biochemical approach. Thrombosis and haemostasis, 2008, Volume: 100, Issue:4 Topics: Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2008
Overcoming "resistance" to aspirin and clopidogrel with tirofiban: fact or fiction? Thrombosis and haemostasis, 2008, Volume: 100, Issue:4 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Tyrosine	2008
The challenge of monitoring platelet response after clopidogrel. European heart journal, 2008, Volume: 29, Issue:23 Topics: Blood Platelets; Clopidogrel; Coronary Disease; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine	2008
Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent. Thrombosis research, 2009, Volume: 124, Issue:1 Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2009
Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery. International journal of cardiology, 2010, Apr-01, Volume: 140, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Occlusion; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Electrocardiography; Fatal Outcome; Humans; Immunosuppressive Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Sirolimus; Tetrazoles; Ticlopidine; Ventricular Fibrillation	2010
Very late stent thrombosis after discontinuation of clopidogrel therapy. The Medical journal of Australia, 2009, Feb-02, Volume: 190, Issue:3 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Prosthesis Failure; Ticlopidine; Time Factors; Withholding Treatment	2009
Knowledge of coronary stents, thrombosis and dual antiplatelet therapy among Spanish dentists. Revista espanola de cardiologia, 2009, Volume: 62, Issue:2 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Cross-Sectional Studies; Dentists; Health Knowledge, Attitudes, Practice; Humans; Platelet Aggregation Inhibitors; Spain; Stents; Surveys and Questionnaires; Ticlopidine	2009
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis. The American journal of cardiology, 2009, Mar-15, Volume: 103, Issue:6 Topics: Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Ticlopidine	2009
Very late stent thrombosis after discontinuation of clopidogrel therapy. The Medical journal of Australia, 2009, Feb-02, Volume: 190, Issue:3 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Prosthesis Failure; Ticlopidine; Time Factors; Withholding Treatment	2009
Very late drug-eluting stent thrombosis after nonsteroidal anti-inflammatory drug treatment despite dual antiplatelet therapy. The Canadian journal of cardiology, 2009, Volume: 25, Issue:4 Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Cyclooxygenase Inhibitors; Diabetic Angiopathies; Diclofenac; Drug Interactions; Drug-Eluting Stents; Endothelium, Vascular; Humans; Intervertebral Disc Displacement; Male; Meloxicam; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Thiazines; Thiazoles; Ticlopidine; Time Factors	2009
Combined, superselective pharmacological management of large coronary thrombus burden. The Journal of invasive cardiology, 2009, Volume: 21, Issue:4 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Registries; Stents; Ticlopidine; Urokinase-Type Plasminogen Activator	2009
Bridging with GP IIb/IIIa inhibitors after abdominal surgery in a patient presenting with late stent thrombosis of a drug-eluting stent and who cannot receive oral antiplatelet treatment. The Journal of invasive cardiology, 2009, Volume: 21, Issue:4 Topics: Administration, Oral; Aged; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Perioperative Care; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoprotein IIb; Ticlopidine; Time Factors	2009
[Late thrombosis in paclitaxel-eluting stent after discontinuation of clopidogrel medication - a case report with 2-year follow-up]. Kardiologia polska, 2009, Volume: 67, Issue:3 Topics: Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2009
Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system. JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Durapatite; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Prosthesis Design; Registries; Sirolimus; Stainless Steel; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2008
A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:5 Topics: Analysis of Variance; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Ticlopidine; Time Factors; Ultrasonography, Interventional	2009
Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Japan; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Sirolimus; Ticlopidine; Tomography, Optical Coherence; Ultrasonography, Interventional	2009
Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. Journal of the American College of Cardiology, 2009, Jun-02, Volume: 53, Issue:22 Topics: Adult; Aged; Clopidogrel; Confidence Intervals; Coronary Aneurysm; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Databases as Topic; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Ultrasonography, Interventional	2009
Future of oral antiplatelet therapy: four challenged hypotheses. Thrombosis and haemostasis, 2009, Volume: 101, Issue:6 Topics: Adenosine; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Cost-Benefit Analysis; Hemorrhage; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Prognosis; Purinergic P2 Receptor Antagonists; Pyridines; Risk Assessment; Survival Rate; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2009
Tailored medical and interventional therapy against recurrent stent thrombosis after drug-eluting stenting. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2010, Volume: 16, Issue:5 Topics: Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Ticlopidine	2010
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation, 2009, Jun-30, Volume: 119, Issue:25 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Combined Modality Therapy; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Registries; Retrospective Studies; Tetrazoles; Ticlopidine	2009
New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry. The Journal of invasive cardiology, 2009, Volume: 21, Issue:8 Topics: Aged; Argentina; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2009
Drug-specific thienopyridine resistance in patient with recurrent coronary stent thrombosis. The Journal of invasive cardiology, 2009, Volume: 21, Issue:8 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug Resistance; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Secondary Prevention; Stents; Ticlopidine	2009
Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis. The American journal of cardiology, 2009, Aug-15, Volume: 104, Issue:4 Topics: Aged; Aspirin; Case-Control Studies; Clopidogrel; Cohort Studies; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prevalence; Ticlopidine	2009
Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2010, Volume: 16, Issue:1 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Shock, Cardiogenic; Stents; Ticlopidine	2010
Platelet antiaggregants in pregnancy. Revista espanola de cardiologia, 2009, Volume: 62, Issue:10 Topics: Abciximab; Adult; Antibodies, Monoclonal; Clopidogrel; Coronary Thrombosis; Female; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Cardiovascular; Ticlopidine	2009
Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients. The American journal of cardiology, 2009, Oct-15, Volume: 104, Issue:8 Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Blood Proteins; Cell Adhesion Molecules; Clopidogrel; Coronary Thrombosis; Electrocardiography; Female; Humans; Male; Microfilament Proteins; Middle Aged; Odds Ratio; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Prosthesis Failure; Risk Factors; ROC Curve; Stents; Ticlopidine	2009
Time does not heal every wound: coronary stent thrombosis of a bare-metal stent more than one decade after its implantation. Platelets, 2009, Volume: 20, Issue:8 Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2009
Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). The American journal of cardiology, 2009, Nov-15, Volume: 104, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stents; Ticlopidine; Time Factors	2009
Perioperative management of the patient with a coronary stent. Current opinion in anaesthesiology, 2010, Volume: 23, Issue:1 Topics: Algorithms; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Graft Occlusion, Vascular; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Time Factors	2010
High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease. Circulation, 2009, Dec-01, Volume: 120, Issue:22 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Death, Sudden, Cardiac; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk Factors; Ticlopidine	2009
Potential Interaction between clopidogrel and proton pump inhibitors. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2009, Volume: 9, Issue:6 Topics: Acute Coronary Syndrome; Clopidogrel; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome	2009
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should be continued for more than one year and preferably indefinitely. Circulation. Cardiovascular interventions, 2008, Volume: 1, Issue:3 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors	2008
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?: Dual antiplatelet therapy after drug-eluting stents should not be continued for more than 1 year and preferably indefinitely. Circulation. Cardiovascular interventions, 2008, Volume: 1, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Loss, Surgical; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors	2008
Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery. Heart, lung & circulation, 2010, Volume: 19, Issue:1 Topics: Anticoagulants; Aspirin; Australia; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Heparin; Humans; New Zealand; Platelet Aggregation Inhibitors; Preoperative Care; Ticlopidine	2010
[Antiplatelet therapy and urgent surgical procedures. Acute appendicitis two days after stent implantation--a case report]. Kardiologia polska, 2009, Volume: 67, Issue:12 Topics: Appendicitis; Clopidogrel; Coronary Thrombosis; Dobutamine; Humans; Intraoperative Complications; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Complications; Reoperation; Stents; Ticlopidine	2009
Subacute coronary stent thrombosis in a patient with angina treated with double antiplatelet drugs for six days. Chinese medical journal, 2009, Oct-05, Volume: 122, Issue:19 Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine	2009
Cytochrome 2C1917 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement. Circulation, 2010, Feb-02, Volume: 121, Issue:4* Topics: Aged; Aryl Hydrocarbon Hydroxylases; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Gene Frequency; Genotype; Hemorrhage; Heterozygote; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2010
Genotyping, clopidogrel metabolism, and the search for the therapeutic window of thienopyridines. Circulation, 2010, Feb-02, Volume: 121, Issue:4 Topics: Aryl Hydrocarbon Hydroxylases; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Gene Frequency; Genotype; Humans; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Pyridines; Ticlopidine	2010
Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents. The Journal of invasive cardiology, 2010, Volume: 22, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome; Warfarin	2010
Very late drug-eluting stent thrombosis in the perioperative period of endoscopic choledocholithotomy. Acta cardiologica, 2009, Volume: 64, Issue:6 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Endoscopy, Digestive System; Gallstones; Humans; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors	2009
Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years. Journal of the American College of Cardiology, 2010, Feb-16, Volume: 55, Issue:7 Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Creatinine; Diabetes Mellitus; Drug-Eluting Stents; Follow-Up Studies; Humans; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Sirolimus; Stroke Volume; Ticlopidine	2010
Acute myocardial infarction related to very late sirolimus-eluting stent thrombosis 6 months after discontinuation of dual antiplatelet therapy. Journal of cardiovascular medicine (Hagerstown, Md.), 2011, Volume: 12, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prosthesis Design; Sirolimus; Ticlopidine; Time Factors	2011
The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response. Thrombosis and haemostasis, 2010, Volume: 103, Issue:5 Topics: Aged; Amlodipine; Angioplasty; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Platelets; Calcium Channel Blockers; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Complications; Prospective Studies; Ticlopidine	2010
[Recurrent stent thrombosis in a patient with non-ST-segment elevation acute coronary syndrome]. Kardiologia polska, 2010, Volume: 68, Issue:3 Topics: Acute Coronary Syndrome; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Resistance; Electrocardiography; Equipment Failure Analysis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine	2010
[Thrombosis of pharmacoactive coronary endoprothesis after stopping antiplatelet treatment]. La Tunisie medicale, 2010, Volume: 88, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cholecystectomy, Laparoscopic; Cholecystolithiasis; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Treatment Outcome	2010
Thrombus too big for pharmacology alone? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, May-01, Volume: 75, Issue:6 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Combined Modality Therapy; Coronary Thrombosis; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Radiography; Thrombectomy; Thrombolytic Therapy; Ticlopidine	2010
Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation. American heart journal, 2010, Volume: 159, Issue:5 Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardium; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2010
Late and very late stent thrombosis after polymer-based sirolimus- or paclitaxel-eluting stent implantation in real-world clinical practice. Chinese medical journal, 2010, Apr-05, Volume: 123, Issue:7 Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug-Eluting Stents; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Polymers; Sirolimus; Ticlopidine	2010
Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results. Chinese medical journal, 2010, Apr-05, Volume: 123, Issue:7 Topics: Aged; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine	2010
Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions. Clinical research in cardiology : official journal of the German Cardiac Society, 2010, Volume: 99, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Biomarkers; Blood Glucose; C-Reactive Protein; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Cytokines; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoassay; Inflammation; Male; Pilot Projects; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine; Treatment Outcome	2010
The evidence base for platelet function testing in patients undergoing percutaneous coronary intervention. Circulation. Cardiovascular interventions, 2010, Jun-01, Volume: 3, Issue:3 Topics: Acute Coronary Syndrome; Atherectomy; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Diagnostic Tests, Routine; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Implantation; Ticlopidine	2010
Management of perioperative stent thrombosis in patients undergoing surgery. Platelets, 2010, Volume: 21, Issue:7 Topics: Aged; Aspirin; Cardiac Surgical Procedures; Clopidogrel; Coronary Thrombosis; Humans; Male; Perioperative Period; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2010
Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window. Journal of the American College of Cardiology, 2010, Jul-20, Volume: 56, Issue:4 Topics: Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Hemorrhage; Humans; Platelet Aggregation; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Ticlopidine; Time Factors	2010
Initial experience with an institutional bridging protocol for patients with recent coronary stent implantation requiring discontinuation of dual antiplatelet therapy resulting from urgent surgery. American journal of therapeutics, 2011, Volume: 18, Issue:6 Topics: Antithrombins; Aspirin; Blood Loss, Surgical; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Hirudins; Humans; Peptide Fragments; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Recombinant Proteins; Stents; Surgical Procedures, Operative; Ticlopidine; Time Factors	2011
Recurrent acute stent thrombosis due to allergic reaction secondary to clopidogrel therapy. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Acute Disease; Adult; Clopidogrel; Coronary Thrombosis; Drug Hypersensitivity; Humans; Male; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine	2011
Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents. American heart journal, 2010, Volume: 160, Issue:2 Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Middle Aged; Multivariate Analysis; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine	2010
Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model. Thrombosis and haemostasis, 2010, Volume: 104, Issue:3 Topics: Adenosine; Animals; Bleeding Time; Blood Coagulation; Clopidogrel; Coronary Circulation; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Therapy, Combination; Echocardiography; Female; Fibrinolytic Agents; Laser-Doppler Flowmetry; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Thrombolytic Therapy; Ticagrelor; Ticlopidine; Time Factors; Tissue Plasminogen Activator	2010
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. Journal of the American College of Cardiology, 2010, Sep-14, Volume: 56, Issue:12 Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2 Receptor Antagonists; Risk Factors; ROC Curve; Stents; Ticlopidine	2010
Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy. The American journal of cardiology, 2010, Nov-01, Volume: 106, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Chi-Square Distribution; Clopidogrel; Combined Modality Therapy; Coronary Thrombosis; Creatine Kinase; Echocardiography; Female; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prevalence; Statistics, Nonparametric; Stents; Ticlopidine; Tomography, Emission-Computed, Single-Photon	2010
[Between thrombosis and bleeding - a case of paroxysmal nocturnal hemoglobinuria]. Therapeutische Umschau. Revue therapeutique, 2010, Volume: 67, Issue:12 Topics: Aged; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Fatal Outcome; Female; Hemoglobinuria, Paroxysmal; Heparin; Heparin, Low-Molecular-Weight; Humans; Phenprocoumon; Platelet Aggregation Inhibitors; Ticlopidine; Tomography, X-Ray Computed	2010
Significant increase in clopidogrel use across U.S. children's hospitals. Pediatric cardiology, 2011, Volume: 32, Issue:2 Topics: Adolescent; Child; Child, Preschool; Clopidogrel; Coronary Thrombosis; Databases, Factual; Drug Therapy, Combination; Female; Heart Defects, Congenital; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Inpatients; Length of Stay; Male; Mortality; Pediatrics; Platelet Aggregation Inhibitors; Poisson Distribution; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Stroke; Ticlopidine; United States; Venous Thromboembolism	2011
[Efficacy and safety of concomitant use of rabeprazole during dual-antiplatelet therapy with clopidogrel and aspirin after drug-eluting stent implantation: a retrospective cohort study]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2010, Volume: 130, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; Clopidogrel; Cohort Studies; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Interactions; Drug-Eluting Stents; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Ticlopidine; Treatment Outcome	2010
What is the optimal duration of triple anti-platelet therapy in patients with acute myocardial infarction undergoing drug-eluting stent implantation? Journal of cardiology, 2011, Volume: 57, Issue:1 Topics: Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Tetrazoles; Ticlopidine; Time Factors	2011
Behind the paper: stepping up to the antiplatelet. Nature medicine, 2011, Volume: 17, Issue:1 Topics: Amino Acid Sequence; Aryldialkylphosphatase; Aspirin; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 Enzyme System; Drug Tolerance; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine	2011
Management of clopidogrel hypersensitivity without drug interruption. The American journal of cardiology, 2011, Mar-15, Volume: 107, Issue:6 Topics: Adrenal Cortex Hormones; Cardiac Catheterization; Clopidogrel; Coronary Thrombosis; Drug Hypersensitivity; Drug-Eluting Stents; Female; Histamine Antagonists; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome	2011
Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding St The American journal of cardiology, 2011, Apr-01, Volume: 107, Issue:7 Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hemorrhage; Humans; Long-Term Care; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Point-of-Care Systems; Predictive Value of Tests; Premedication; Prospective Studies; Receptors, Purinergic P2Y12; Stents; Ticlopidine	2011
Recurrent myocardial infarction due to one subacute and two very late thrombotic events of drug-eluting stent associated with clopidogrel resistance. The Journal of invasive cardiology, 2011, Volume: 23, Issue:2 Topics: Adult; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Electrocardiography; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Secondary Prevention; Ticlopidine; Treatment Outcome	2011
Recurrent episodes of very late stent thrombosis in a patient with aspirin hypersensitivity, stent fracture and malapposition. Acute cardiac care, 2011, Volume: 13, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Occlusion; Coronary Thrombosis; Drug Hypersensitivity; Drug-Eluting Stents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Failure; Recurrence; Ticlopidine; Time Factors; Tomography, Optical Coherence	2011
Treatment patterns in acute coronary syndrome patients in the United Kingdom undergoing PCI. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2011, Volume: 6, Issue:8 Topics: Acute Coronary Syndrome; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Female; Humans; Length of Stay; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prospective Studies; Registries; Retreatment; Stents; Ticlopidine; United Kingdom	2011
[Coronary stent thrombosis in concurrent clopidogrel and proton pump inhibitor therapy]. Ugeskrift for laeger, 2011, Feb-28, Volume: 173, Issue:9 Topics: Clopidogrel; Coronary Thrombosis; Drug Interactions; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2011
Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions. American heart journal, 2011, Volume: 161, Issue:3 Topics: Acute Coronary Syndrome; Adenosine; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Humans; Lactones; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Pyridines; Quinazolinones; Randomized Controlled Trials as Topic; Receptor, PAR-1; Sulfonamides; Ticagrelor; Ticlopidine	2011
Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting. American heart journal, 2011, Volume: 161, Issue:3 Topics: Aged; Calcium Channel Blockers; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug Synergism; Drug-Eluting Stents; Endpoint Determination; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine	2011
Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy. Cardiology, 2011, Volume: 118, Issue:1 Topics: Adult; Aspirin; Clopidogrel; Coronary Thrombosis; Eptifibatide; Female; Fibrinolytic Agents; Heparin; Humans; Lupus Erythematosus, Systemic; Peptides; Platelet Aggregation Inhibitors; Ticlopidine	2011
Comparison of two murine models of thrombosis induced by atherosclerotic plaque injury. Thrombosis and haemostasis, 2011, Volume: 105 Suppl 1 Topics: Animals; Apolipoproteins E; Blood Platelets; Carotid Arteries; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; High-Energy Shock Waves; Humans; Immunohistochemistry; Mice; Mice, Knockout; Plaque, Atherosclerotic; Platelet Activation; Ticlopidine	2011
[Multiple arterial thrombosis and resistance to conventional antiaggregation]. Revista espanola de cardiologia, 2011, Volume: 64, Issue:9 Topics: Aged; Angiography; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Resistance; Electrocardiography; Female; Femoral Artery; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Thrombosis; Ticlopidine	2011
Massive thrombus burden with recurrence of intracoronary thrombosis early after stenting and delayed onset of prasugrel action in a patient with ST-elevation myocardial infarction and cardiac shock. Thrombosis and haemostasis, 2011, Volume: 106, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiopulmonary Resuscitation; Catecholamines; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Interactions; Electrocardiography; Female; Heart Arrest; Humans; Myocardial Infarction; Piperazines; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Recurrence; Stents; Thiophenes; Ticlopidine; Time Factors	2011
Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Sep-01, Volume: 80, Issue:3 Topics: Aged; Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hospitals, High-Volume; Humans; Italy; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Tacrolimus; Ticlopidine; Time Factors; Treatment Outcome	2012
Influence of low-dose aspirin (81 mg) on the incidence of definite stent thrombosis in patients receiving bare-metal and drug-eluting stents. Clinical cardiology, 2011, Volume: 34, Issue:9 Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Sirolimus; Statistics as Topic; Ticlopidine	2011
Recent trends in Australian percutaneous coronary intervention practice: insights from the Melbourne Interventional Group registry. The Medical journal of Australia, 2011, Aug-01, Volume: 195, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Australia; Clopidogrel; Comorbidity; Coronary Occlusion; Coronary Restenosis; Coronary Thrombosis; Diabetes Mellitus; Drug Utilization; Drug-Eluting Stents; Emergencies; Female; Hemorrhage; Hospital Mortality; Humans; Logistic Models; Male; Myocardial Infarction; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Renal Insufficiency; Shock, Cardiogenic; Ticlopidine	2011
Influence of platelet reactivity on outcome of patients with acute myocardial infarction undergoing primary angioplasty. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:9 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine	2011
Antiplatelet therapy in percutaneous coronary intervention: is variability of response clinically relevant? Heart (British Cardiac Society), 2011, Volume: 97, Issue:17 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Thrombosis; Drug Therapy, Combination; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2011
Stent-related cardiac events beyond three years after implantation of the sirolimus-eluting stent (from the EVASTENT Patients). The American journal of cardiology, 2011, Nov-15, Volume: 108, Issue:10 Topics: Clopidogrel; Cohort Studies; Coronary Artery Disease; Coronary Thrombosis; Diabetes Mellitus; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Matched-Pair Analysis; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Registries; Sirolimus; Ticlopidine	2011
Optical coherence tomography findings during "evolving" stent thrombosis. The Journal of invasive cardiology, 2011, Volume: 23, Issue:9 Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Aspirin; Cardiopulmonary Resuscitation; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stents; Ticlopidine; Tomography, Optical Coherence; Ultrasonography, Interventional	2011
Intravascular ultrasound and angiographic demonstration of left main stem thrombus-high-risk presentation in a young adult with anabolic steroid abuse. The American heart hospital journal, 2010,Winter, Volume: 8, Issue:2 Topics: Abciximab; Anabolic Agents; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Humans; Immunoglobulin Fab Fragments; Male; Platelet Aggregation Inhibitors; Substance-Related Disorders; Ticlopidine; Ultrasonography, Interventional; Young Adult	2010
Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Sep-01, Volume: 80, Issue:3 Topics: Aged; Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Incidence; Italy; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prevalence; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome	2012
Relationship between cytochrome P450 2C192 polymorphism and stent thrombosis following percutaneous coronary intervention in Chinese patients receiving clopidogrel. The Journal of international medical research, 2011, Volume: 39, Issue:5* Topics: Aged; Aged, 80 and over; Amplified Fragment Length Polymorphism Analysis; Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; China; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Proportional Hazards Models; Ticlopidine	2011
Renal function assessed using cystatin C and antiplatelet efficacy of clopidogrel assessed using the vasodilator-stimulated phosphoprotein index in patients having percutaneous coronary intervention. The American journal of cardiology, 2012, Mar-01, Volume: 109, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Blood Proteins; Cell Adhesion Molecules; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Cystatin C; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Immunoassay; Kidney Function Tests; Male; Microfilament Proteins; Phosphoproteins; Platelet Aggregation Inhibitors; Prognosis; Stents; Ticlopidine	2012
Low mean corpuscular hemoglobin level is a predictor of discontinuation of antiplatelet therapy in patients with acute coronary syndrome. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:24 Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Erythrocyte Indices; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Platelet Aggregation Inhibitors; Risk Factors; Stents; Ticlopidine	2011
"Conversations in cardiology": How do you pick the best antiplatelet drug--clopidogrel, prasugrel, ticagrelor for your PCI patient? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Feb-01, Volume: 79, Issue:2 Topics: Adenosine; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Decision Making; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine; Treatment Outcome	2012
The safety of major head and neck surgery in patients taking clopidogrel (Plavix). Plastic and reconstructive surgery, 2012, Volume: 129, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clopidogrel; Coronary Thrombosis; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Retrospective Studies; Ticlopidine; Young Adult	2012
Acute stent thrombosis: technical complication or inadequate antithrombotic therapy? An optical coherence tomography study. JACC. Cardiovascular interventions, 2012, Volume: 5, Issue:2 Topics: Acute Disease; Aged; Antithrombins; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Eptifibatide; Female; Fibrinolytic Agents; Heparin; Hirudins; Humans; Peptide Fragments; Peptides; Platelet Aggregation Inhibitors; Recombinant Proteins; Risk Factors; Ticlopidine; Tomography, Optical Coherence	2012
Short thromboelastography and the identification of high platelet reactivity while on and off therapy. Heart (British Cardiac Society), 2012, Volume: 98, Issue:9 Topics: Clopidogrel; Coronary Thrombosis; Drug Resistance; Female; Graft Occlusion, Vascular; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Registries; Ticlopidine	2012
Personalised antiplatelet therapy in stent thrombosis: observations from the Clopidogrel Resistance in Stent Thrombosis (CREST) registry. Heart (British Cardiac Society), 2012, Volume: 98, Issue:9 Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Resistance; Electrocardiography; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Registries; Thrombelastography; Ticlopidine; Treatment Outcome; United Kingdom	2012
Very late thrombosis of a paclitaxel-eluting stent after 72 months in a patient on dual anti-platelet therapy. Cardiovascular journal of Africa, 2012, Apr-12, Volume: 23, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Echocardiography; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticlopidine; Time Factors	2012
Pharmacodynamic effect of clopidogrel therapy and switching to cilostazol in patients with the CYP2C19 loss-of-function allele (ACCEL-SWITCH) study. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:8 Topics: Angioplasty, Balloon, Coronary; Aryl Hydrocarbon Hydroxylases; Asian People; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Genotype; Heterozygote; Homozygote; Humans; Phenotype; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Republic of Korea; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome	2012
Simultaneous subacute thrombosis of bare metal coronary stents in two different arteries early after clopidogrel cessation. Cardiology journal, 2012, Volume: 19, Issue:3 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Administration Schedule; Electrocardiography; Female; Humans; Medication Adherence; Metals; Middle Aged; Platelet Aggregation Inhibitors; Prosthesis Design; Stents; Ticlopidine; Time Factors; Treatment Outcome	2012
Simultaneous thromboses of two coronary arteries in a heavy smoker woman: a singular case of acute myocardial infarction. Minerva cardioangiologica, 2012, Volume: 60, Issue:4 Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Smoking; Stents; Ticlopidine; Time Factors; Treatment Outcome	2012
Atopaxar: a review of its mechanism of action and role in patients with coronary artery disease. Future cardiology, 2012, Volume: 8, Issue:4 Topics: Acute Coronary Syndrome; Animals; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Humans; Imines; Platelet Activation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Thrombin; Ticlopidine	2012
Early and late outcome associated with bleeding events in the setting of dual antiplatelet therapy following stent placement. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Sep-01, Volume: 80, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticlopidine	2012
Less may be more: insights on dual antiplatelet therapy duration after drug-eluting stent implantation from the MATRIX registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2012, Sep-01, Volume: 80, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Tacrolimus; Ticlopidine	2012
Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction. International journal of cardiology, 2013, Sep-10, Volume: 167, Issue:6 Topics: Aged; Aged, 80 and over; Aryl Hydrocarbon Hydroxylases; Blood Platelets; Clopidogrel; Cohort Studies; Coronary Thrombosis; Cyclooxygenase 1; Cytochrome P-450 CYP2C19; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Pharmacogenetics; Platelet Aggregation; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Population Surveillance; Stents; Ticlopidine	2013
Understand the power of Plavix. This antiplatelet drug prevents in-stent clots in women as well as men. Heart advisor, 2010, Volume: 13, Issue:4 Topics: Angioplasty, Balloon; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Drug-Eluting Stents; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine; Women's Health	2010
Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction. JACC. Cardiovascular interventions, 2012, Volume: 5, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Confidence Intervals; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Myocardial Reperfusion; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; United States	2012
Effects of pre-hospital clopidogrel administration on early and late residual platelet reactivity in ST-segment elevation myocardial infarction patients undergoing primary intervention. Journal of thrombosis and haemostasis : JTH, 2013, Volume: 11, Issue:1 Topics: Aged; Belgium; Blood Platelets; Clopidogrel; Coronary Thrombosis; Drug Administration Schedule; Emergency Medical Services; Female; Humans; Ischemic Attack, Transient; Italy; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Recurrence; Stents; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2013
A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2012, Nov-22, Volume: 8, Issue:7 Topics: Absorbable Implants; Aged; Aspirin; Cardiovascular Agents; China; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Disease-Free Survival; Drug Therapy, Combination; Drug-Eluting Stents; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Propensity Score; Proportional Hazards Models; Prospective Studies; Prosthesis Design; Registries; Risk Assessment; Risk Factors; Sirolimus; Ticlopidine; Time Factors; Treatment Outcome	2012
Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry. Cardiovascular intervention and therapeutics, 2013, Volume: 28, Issue:2 Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Incidence; Japan; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Prospective Studies; Registries; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2013
Cardiovascular risk among patients on clopidogrel anti-platelet therapy after placement of drug-eluting stents is modified by genetic variants in both the CYP2C19 and ABCB1 genes. Thrombosis and haemostasis, 2013, Volume: 109, Issue:4 Topics: Aged; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chi-Square Distribution; Clopidogrel; Coronary Thrombosis; Cytochrome P-450 CYP2C19; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Pharmacogenetics; Phenotype; Platelet Aggregation Inhibitors; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Risk Factors; Ticlopidine; Time Factors; Treatment Outcome	2013
A case of in-stent thrombosis in a patient with drug eluting stents during perioperative management with glycoprotein IIb/IIIa inhibitors. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Dec-01, Volume: 82, Issue:7 Topics: Aged; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug Substitution; Drug Therapy, Combination; Drug-Eluting Stents; Eptifibatide; Female; Humans; Neurosurgical Procedures; Peptides; Percutaneous Coronary Intervention; Perioperative Period; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Ticlopidine; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2013
Ambulatory use of ticlopidine and clopidogrel in association with percutaneous coronary revascularization procedures in a national managed care organization. Journal of interventional cardiology, 2002, Volume: 15, Issue:3 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Retrospective Studies; Stents; Ticlopidine; Time Factors; Treatment Outcome	2002
Clopidogrel as an antiplatelet agent in transplant heart coronary stenting. Journal of interventional cardiology, 2002, Volume: 15, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Heart Transplantation; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome	2002
Large intracoronary thrombi with good TIMI flow during acute myocardial infarction: four cases of successful aggressive medical management in patients without angiographically detectable coronary atherosclerosis. Heart (British Cardiac Society), 2002, Volume: 88, Issue:5 Topics: Abciximab; Adult; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Coronary Circulation; Coronary Thrombosis; Drug Therapy, Combination; Female; Heparin; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine	2002
Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry. Journal of the American College of Cardiology, 2002, Nov-06, Volume: 40, Issue:9 Topics: Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2002
Onset and extent of platelet inhibition by clopidogrel loading in patients undergoing elective coronary stenting: the Plavix Reduction Of New Thrombus Occurrence (PRONTO) trial. American heart journal, 2003, Volume: 145, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Antigens, CD; Clopidogrel; Collagen; Coronary Disease; Coronary Thrombosis; Drug Administration Schedule; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Single-Blind Method; Stents; Tetraspanin 24; Ticlopidine	2003
Introduction to "Optimizing management of non-ST-segment elevation acute coronary syndromes". Harmonizing advances in mechanical and pharmacologic intervention. Journal of the American College of Cardiology, 2003, Feb-19, Volume: 41, Issue:4 Suppl S Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Cardiac Catheterization; Clopidogrel; Coronary Thrombosis; Electrocardiography; Eptifibatide; Humans; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Ticlopidine	2003
Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2003, Volume: 59, Issue:3 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Case-Control Studies; Cell Adhesion Molecules; Chi-Square Distribution; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Female; Flow Cytometry; Humans; Male; Microfilament Proteins; Middle Aged; Monitoring, Physiologic; Phosphoproteins; Pilot Projects; Platelet Aggregation Inhibitors; Premedication; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Stents; Ticlopidine; Treatment Outcome	2003
[Effects of antiaggregants on concentration of plasma cytokines in patients with acute coronary syndrome]. Klinicheskaia meditsina, 2003, Volume: 81, Issue:6 Topics: Acute Disease; Aspirin; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Cytokines; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine	2003
Clopidogrel versus ticlopidine after the placement of coronary artery stents. Journal of the American College of Cardiology, 2003, Aug-20, Volume: 42, Issue:4 Topics: Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Humans; Myocardial Revascularization; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine; Treatment Outcome	2003
Are we making efficient use of clopidogrel? European heart journal, 2004, Volume: 25, Issue:6 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine	2004
Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions. European heart journal, 2004, Volume: 25, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine	2004
Resistance to antiplatelet drugs: is it real or relevant? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004, Volume: 62, Issue:1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Brachytherapy; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors	2004
Late stent thrombosis (> 1 year) following clopidogrel withdrawal after brachytherapy treatment: need to assess aspirin resistance? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004, Volume: 62, Issue:1 Topics: Adult; Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Brachytherapy; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Graft Occlusion, Vascular; Humans; Male; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors	2004
PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:1 Topics: Abciximab; Adenosine Diphosphate; Aged; Amino Acid Substitution; Antibodies, Monoclonal; Aspirin; Blood Platelets; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Heterozygote; Homozygote; Humans; Immunoglobulin Fab Fragments; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Stents; Ticlopidine; Treatment Outcome	2004
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation, 2004, Jun-29, Volume: 109, Issue:25 Topics: Adenosine Diphosphate; Aged; Aspirin; Biotransformation; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Epinephrine; Eptifibatide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Prospective Studies; Purinergic P2 Receptor Antagonists; Recurrence; Risk; Smoking; Stents; Ticlopidine; Treatment Outcome	2004
[New antiplatelet agents (platelet receptor blockers): has aspirin come out of place?]. Praxis, 2004, Jun-02, Volume: 93, Issue:23 Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Secondary Prevention; Thrombophilia; Ticlopidine; Treatment Outcome	2004
[What should one pay attention to during surgery shortly after brachytherapy with coated stents?]. Deutsche medizinische Wochenschrift (1946), 2004, Jul-09, Volume: 129, Issue:28-29 Topics: Angioplasty, Balloon, Coronary; Aspirin; Brachytherapy; Clopidogrel; Contraindications; Coronary Thrombosis; Elective Surgical Procedures; Emergency Treatment; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stents; Ticlopidine; Time Factors	2004
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, Volume: 126, Issue:3 Suppl Topics: Administration, Oral; Aspirin; Clopidogrel; Coronary Thrombosis; Evidence-Based Medicine; Humans; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism; Ticlopidine; Treatment Outcome	2004
Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combination. Thrombosis and haemostasis, 2004, Volume: 92, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Middle Aged; Practice Guidelines as Topic; Stents; Ticlopidine; Time Factors	2004
[Antiplatelet strategies in the acute and chronic therapy of cardiovascular disease]. Medizinische Klinik (Munich, Germany : 1983), 2004, Aug-15, Volume: 99 Suppl 1 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Long-Term Care; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine	2004
Antiplatelet therapy in non-ST-segment elevation acute coronary syndromes. JAMA, 2004, Oct-20, Volume: 292, Issue:15 Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Eptifibatide; Heparin; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Stents; Ticlopidine; Vasodilator Agents	2004
Subacute coronary stent thrombosis in a patient developing clopidogrel associated thrombotic thrombocytopenic purpura. Heart (British Cardiac Society), 2005, Volume: 91, Issue:2 Topics: Aged; Angina, Unstable; Blood Vessel Prosthesis; Clopidogrel; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Humans; Male; Platelet Aggregation Inhibitors; Prosthesis Failure; Purpura, Thrombotic Thrombocytopenic; Recurrence; Stents; Ticlopidine	2005
Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda. Circulation, 2005, Mar-08, Volume: 111, Issue:9 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Eptifibatide; Hemorrhage; Length of Stay; Membrane Proteins; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Risk Factors; Stents; Thrombophilia; Ticlopidine	2005
[Exercise-induced left arm pain and thrombocytosis]. Praxis, 2005, Apr-13, Volume: 94, Issue:15 Topics: Angioplasty, Balloon, Coronary; Bone Marrow Examination; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Stenosis; Coronary Thrombosis; Diagnosis, Differential; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Count; Risk Factors; Smoking; Stents; Thrombocythemia, Essential; Ticlopidine	2005
Very late thrombosis after implantation of sirolimus eluting stent. Heart (British Cardiac Society), 2005, Volume: 91, Issue:6 Topics: Adult; Aspirin; Blood Vessel Prosthesis; Catheterization; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Implants; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Prosthesis Failure; Retreatment; Sirolimus; Stents; Ticlopidine; Time Factors	2005
Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era. The American journal of cardiology, 2005, Jun-15, Volume: 95, Issue:12 Topics: Acute Disease; Anticoagulants; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Clopidogrel; Coated Materials, Biocompatible; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Therapy, Combination; Electrocardiography; Female; Heparin; Humans; Intraoperative Complications; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Predictive Value of Tests; Pyridines; Retrospective Studies; Stents; Thrombolytic Therapy; Ticlopidine; Treatment Outcome	2005
Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation. International journal of cardiology, 2005, Sep-01, Volume: 103, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine	2005
What is the best measure of thrombotic risks--pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2005, Volume: 66, Issue:4 Topics: Blood Vessel Prosthesis Implantation; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome	2005
Optimal antiplatelet treatment for percutaneous coronary intervention: clopidogrel vs. ticlopidine. International journal of cardiology, 2007, Jan-02, Volume: 114, Issue:1 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug Interactions; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2007
Antiplatelet therapy after percutaneous coronary intervention. Cerebrovascular diseases (Basel, Switzerland), 2006, Volume: 21 Suppl 1 Topics: Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stents; Tetrazoles; Ticlopidine; Time Factors	2006
Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina. Thrombosis and haemostasis, 2006, Volume: 95, Issue:2 Topics: Acute Disease; Angina, Unstable; Animals; Aspirin; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Drug Therapy, Combination; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Swine; Ticlopidine	2006
Successful lysis of coronary thrombi by long term warfarin treatment after a failed course of tirofiban infusion. International journal of cardiology, 2006, Mar-22, Volume: 108, Issue:1 Topics: Angina Pectoris; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Enoxaparin; Female; Humans; Infusion Pumps; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Tirofiban; Treatment Failure; Treatment Outcome; Tyrosine; Warfarin	2006
Pharmacologic inhibition of platelet vWF-GPIb alpha interaction prevents coronary artery thrombosis. Thrombosis and haemostasis, 2006, Volume: 95, Issue:3 Topics: Animals; Bleeding Time; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eptifibatide; Fibrinolytic Agents; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Recombinant Fusion Proteins; Ticlopidine; Time Factors; Vascular Patency; von Willebrand Factor	2006
Suspected clopidogrel resistance in a patient with acute stent thrombosis. Nature clinical practice. Cardiovascular medicine, 2006, Volume: 3, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Drug Resistance; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Prosthesis Failure; Recurrence; Risk Assessment; Stents; Ticlopidine; Treatment Outcome	2006
Combined aspirin and clopidogrel resistance associated with recurrent coronary stent thrombosis. Clinical research in cardiology : official journal of the German Cardiac Society, 2006, Volume: 95, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Female; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine; Treatment Failure	2006
Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin. The Journal of invasive cardiology, 2006, Volume: 18, Issue:6 Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Coagulation Disorders; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Female; Humans; Hyperhomocysteinemia; Lupus Erythematosus, Systemic; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Time Factors	2006
Clopidogrel-associated thrombotic thrombocytopenic purpura presenting with coronary artery thrombosis. American journal of hematology, 2006, Volume: 81, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Female; Humans; L-Lactate Dehydrogenase; Plasmapheresis; Platelet Aggregation Inhibitors; Platelet Count; Purpura, Thrombotic Thrombocytopenic; Ticlopidine	2006
Use of ticlopidine and cilostazol after intracoronary drug-eluting stent placement in a patient with previous clopidogrel-induced thrombotic thrombocytopenic purpura: a case report. The Journal of invasive cardiology, 2006, Volume: 18, Issue:7 Topics: ADAM Proteins; ADAMTS1 Protein; Aged; Apoptosis; Aspirin; Autoantibodies; Cilostazol; Clopidogrel; Coronary Artery Bypass; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Plasmapheresis; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Stents; Tetrazoles; Ticlopidine	2006
[Combination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMA]. Kardiologiia, 2006, Volume: 46, Issue:5 Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Severity of Illness Index; Ticlopidine; Treatment Outcome	2006
Clinical, biochemical and genetical resistance to clopidogrel in a patient with recurrent stent thrombosis. International journal of cardiology, 2007, Mar-02, Volume: 116, Issue:1 Topics: Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine	2007
The CHARISMA trial and the REACH registry outcomes. Journal of the National Medical Association, 2006, Volume: 98, Issue:10 Topics: Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Humans; Incidence; Platelet Aggregation Inhibitors; Registries; Risk Factors; Ticlopidine; Treatment Outcome	2006
Late thrombosis of drug-eluting stents after discontinuation of clopidogrel: report of two cases and review of the literature. Connecticut medicine, 2006, Volume: 70, Issue:8 Topics: Aged, 80 and over; Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Radiography; Stents; Thrombosis; Ticlopidine; Time Factors; Ultrasonography	2006
Late angiographic stent thrombosis in a drug-eluting stent that occurred 20 months after premature discontinuation of clopidogrel administration. International heart journal, 2006, Volume: 47, Issue:5 Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Humans; Male; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine	2006
A current problem in cardiology: very late thrombosis after implantation of sirolimus eluting stent. Cardiology, 2007, Volume: 108, Issue:4 Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Sirolimus; Ticlopidine; Time Factors	2007
Late ischemic events after clopidogrel cessation following drug-eluting stenting: should we be worried? Journal of the American College of Cardiology, 2006, Dec-19, Volume: 48, Issue:12 Topics: Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Myocardial Ischemia; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2006
A new caution for patients with drug-coated stents. Heart advisor, 2006, Volume: 9, Issue:8 Topics: Clopidogrel; Coronary Disease; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Refusal	2006
Stent thrombosis: consider also low response to antiplatelets. BMJ (Clinical research ed.), 2007, Jan-13, Volume: 334, Issue:7584 Topics: Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Implants; Humans; Platelet Aggregation Inhibitors; Prosthesis Failure; Stents; Ticlopidine	2007
Stent thrombosis: patient card on discontinuing clopidogrel is available. BMJ (Clinical research ed.), 2007, Jan-13, Volume: 334, Issue:7584 Topics: Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug Implants; Humans; Medical Records; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2007
Response to letter of Dr van Werkum et al. International journal of cardiology, 2007, Jun-25, Volume: 119, Issue:1 Topics: Clopidogrel; Coronary Thrombosis; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Ticlopidine	2007
Double-trouble: three cases with simultaneous stent thrombosis in different coronary arteries. Journal of interventional cardiology, 2007, Volume: 20, Issue:2 Topics: Aged; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Coronary Thrombosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stents; Ticlopidine; Time Factors	2007
Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation, 2007, May-08, Volume: 115, Issue:18 Topics: Aged; Angioplasty, Balloon, Coronary; Anthropometry; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Death, Sudden, Cardiac; Drug Implants; Drug Utilization; Endothelium, Vascular; Equipment Design; Equipment Failure; Female; Follow-Up Studies; Humans; Hyperplasia; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Tunica Intima; Wound Healing	2007
A case report of simultaneous thrombosis of two coronary artery stents in association with clopidogrel resistance. Clinical cardiology, 2007, Volume: 30, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine	2007
Late thrombosis of a drug-eluting stent during combined anti-platelet therapy in a clopidogrel nonresponsive diabetic patient: shall we routinely test platelet function? Thrombosis and haemostasis, 2007, Volume: 97, Issue:5 Topics: Aged; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Diabetic Angiopathies; Drug Resistance; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Stents; Ticlopidine	2007
Increased incidence of stent thrombosis in patients with cocaine use. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Jun-01, Volume: 69, Issue:7 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Cocaine-Related Disorders; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Follow-Up Studies; Hospitals, Urban; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Research Design; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome; United States	2007
[Treatment of intrastent restenosis by drug eluting stents: experience from one cardiology centre]. Archives des maladies du coeur et des vaisseaux, 2007, Volume: 100, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Equipment Design; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Paclitaxel; Platelet Aggregation Inhibitors; Prospective Studies; Sirolimus; Stents; Surface Properties; Ticlopidine; Treatment Outcome	2007
Timing of thrombotic events in patients receiving 2 weeks of clopidogrel therapy post bare metal coronary artery stenting: a New Zealand retrospective study. The New Zealand medical journal, 2007, Jun-01, Volume: 120, Issue:1255 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Ticlopidine; Withholding Treatment	2007
Clopidogrel and stent thrombosis after percutaneous coronary intervention. The New Zealand medical journal, 2007, Jun-01, Volume: 120, Issue:1255 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2007
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation, 2007, Jun-26, Volume: 115, Issue:25 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Diabetes Mellitus; Drug Implants; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prospective Studies; Registries; Renal Insufficiency; Risk Factors; Sirolimus; Stents; Ticlopidine; Treatment Outcome	2007
Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease. Heart (British Cardiac Society), 2008, Volume: 94, Issue:6 Topics: Acute Coronary Syndrome; Aged; Aspirin; Clopidogrel; Cohort Studies; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Male; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Stents; Ticlopidine; Treatment Outcome	2008
Confined late stent thrombosis following clopidogrel withdrawal in a patient with multi-segment sirolimus-eluting stent implants. Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:7 Topics: Abciximab; Aged; Angioplasty, Balloon; Antibodies, Monoclonal; Anticoagulants; Clopidogrel; Coronary Artery Disease; Coronary Stenosis; Coronary Thrombosis; Heparin; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine	2007
Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Jul-01, Volume: 70, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Cardiovascular Diseases; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Feasibility Studies; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Metals; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Design; Risk Assessment; Secondary Prevention; Sirolimus; Stents; Ticlopidine; Time Factors; Treatment Outcome	2007
Very late paclitaxel-eluting stent thrombosis despite 21 months of clopidogrel treatment after percutaneous coronary intervention. Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:8 Topics: Acute Disease; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Humans; Male; Middle Aged; Myocardial Ischemia; Paclitaxel; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Prosthesis Design; Stents; Syndrome; Ticlopidine; Time Factors; Treatment Outcome	2007
[Suspected clopidogrel resistance associated with recurrent coronary stent thrombosis--a case report]. Kardiologia polska, 2007, Volume: 65, Issue:7 Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Electrocardiography; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine	2007
Perioperative thrombotic risk of coronary artery stents: possible role for intravenous platelet blockade. Anesthesiology, 2007, Volume: 107, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Injections, Intravenous; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Factors; Stents; Ticlopidine; Tirofiban; Tyrosine	2007
Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation. The Journal of invasive cardiology, 2007, Volume: 19, Issue:9 Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Male; Platelet Aggregation Inhibitors; Sirolimus; Stents; Ticlopidine; Time Factors	2007
Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. Journal of interventional cardiology, 2007, Volume: 20, Issue:5 Topics: Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Heparin; Humans; Hypolipidemic Agents; Retrospective Studies; Risk Factors; Ticlopidine; Treatment Outcome	2007
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin--a persisting dilemma. Internal and emergency medicine, 2007, Volume: 2, Issue:3 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Risk Factors; Ticlopidine; Venous Thrombosis; Warfarin	2007
Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany. Current medical research and opinion, 2008, Volume: 24, Issue:1 Topics: Aged; Aged, 80 and over; Aspirin; Atherosclerosis; Clopidogrel; Cohort Studies; Coronary Thrombosis; Cost-Benefit Analysis; Germany; Humans; Models, Econometric; Myocardial Infarction; Platelet Aggregation Inhibitors; Survival Analysis; Ticlopidine; Treatment Outcome	2008
[Prasugrel, a new thienopyridine]. Hamostaseologie, 2007, Volume: 27, Issue:5 Topics: Clinical Trials, Phase II as Topic; Clopidogrel; Coronary Thrombosis; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Thiophenes; Ticlopidine	2007
Perioperative complications in patients with drug-eluting stents: a three-year audit at Geelong Hospital. Anaesthesia and intensive care, 2007, Volume: 35, Issue:6 Topics: Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Intraoperative Complications; Male; Medical Audit; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Ticlopidine	2007
The success of clopidogrel treatment for recurrent coronary thrombosis in a patient with aortic and mitral valve replacement. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2008, Volume: 14, Issue:4 Topics: Aortic Valve; Clopidogrel; Coronary Thrombosis; Female; Heart Valve Prosthesis; Humans; Middle Aged; Mitral Valve; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine	2008
[Four years of circulatory support with the INCOR axial pump from Berlin Heart]. Archives des maladies du coeur et des vaisseaux, 2007, Volume: 100, Issue:11 Topics: Clopidogrel; Coronary Thrombosis; Enoxaparin; Fibrinolytic Agents; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine	2007
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. European heart journal, 2008, Volume: 29, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Epidemiologic Methods; Female; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Point-of-Care Systems; Prognosis; Ticlopidine	2008
Very late thrombosis in a bare metal stent: an under-recognized problem. The Canadian journal of cardiology, 2008, Volume: 24, Issue:2 Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Stents; Thrombectomy; Ticlopidine	2008
Which patients receiving warfarin can be treated safely with a drug-eluting stent? Heart (British Cardiac Society), 2008, Volume: 94, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Stroke; Ticlopidine; Warfarin	2008
Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents. The Journal of invasive cardiology, 2008, Volume: 20, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Health Care Costs; Humans; Male; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Quebec; Retrospective Studies; Stents; Ticlopidine; Treatment Outcome	2008
Drug-eluting versus bare-metal stents: when and for whom? The Journal of invasive cardiology, 2008, Volume: 20, Issue:3 Topics: Angioplasty, Balloon, Coronary; Canada; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Diabetes Complications; Drug-Eluting Stents; Health Care Costs; Humans; Patient Selection; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2008
Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years? Journal of cardiovascular medicine (Hagerstown, Md.), 2008, Volume: 9, Issue:4 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Radiography; Reoperation; Sirolimus; Ticlopidine; Time Factors	2008
Simultaneous subacute coronary drug-eluting stent thrombosis in two different vessels of a patient with factor V Leiden mutation. Journal of cardiovascular medicine (Hagerstown, Md.), 2008, Volume: 9, Issue:4 Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug-Eluting Stents; Factor V; Humans; Male; Middle Aged; Mutation; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Ticlopidine; Warfarin	2008
Resistance to what, does it matter? How do we study it? European heart journal, 2008, Volume: 29, Issue:8 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Humans; Platelet Aggregation Inhibitors; Point-of-Care Systems; Ticlopidine	2008
Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. American heart journal, 2008, Volume: 155, Issue:4 Topics: Acute Disease; Aged; Analysis of Variance; Case-Control Studies; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Count; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Stents; Ticlopidine	2008
Stent thrombosis--a complication best avoided. The Journal of invasive cardiology, 2008, Volume: 20, Issue:4 Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Heparin; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Risk Factors; Thrombectomy; Ticlopidine	2008
Percutaneous coronary intervention in neurosurgical patients. The Journal of invasive cardiology, 2008, Volume: 20, Issue:4 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Stents; Ticlopidine	2008
Resistance to platelet antiaggregants: an important cause of very late thrombosis of drug eluting stents? Observations from five cases. Archives of cardiovascular diseases, 2008, Volume: 101, Issue:2 Topics: Aged; Aged, 80 and over; Aspirin; Cell Adhesion Molecules; Clopidogrel; Coronary Thrombosis; Drug Resistance; Drug-Eluting Stents; Female; Fibrinolytic Agents; Flow Cytometry; Humans; Male; Microfilament Proteins; Middle Aged; Phosphoproteins; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Ticlopidine	2008
Acute stent thrombosis in a patient with giant cell arteritis. The Canadian journal of cardiology, 2008, Volume: 24, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Giant Cell Arteritis; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Prednisone; Stents; Ticlopidine	2008
Commentary for "Comparison of drug eluting stents with bare metal stents in unselected patients with acute myocardial infarction". Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, May-01, Volume: 71, Issue:6 Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Humans; Metals; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Prosthesis Design; Research Design; Secondary Prevention; Stents; Ticlopidine; Treatment Outcome	2008
Clopidogrel is more effective than aspirin in preventing coronary artery reocclusion after thrombolysis. Transactions of the Association of American Physicians, 1993, Volume: 106 Topics: Animals; Aspirin; Blood Coagulation; Clopidogrel; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Therapy, Combination; Hematocrit; Heparin; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Thrombolytic Therapy; Ticlopidine; Tissue Plasminogen Activator	1993
Clopidogrel is more effective than aspirin as adjuvant treatment to prevent reocclusion after thrombolysis. The American journal of physiology, 1994, Volume: 267, Issue:2 Pt 2 Topics: Animals; Aspirin; Clopidogrel; Coronary Thrombosis; Dogs; Drug Therapy, Combination; Fibrinolytic Agents; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine	1994
[Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation]. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1999, Volume: 18, Issue:6 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine	1999
Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting. The American journal of cardiology, 1999, Sep-15, Volume: 84, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Combined Modality Therapy; Coronary Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Ticlopidine; Treatment Outcome	1999
Studies published on clopidogrel-aspirin for coronary stent placement. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2000, Jan-15, Volume: 57, Issue:2 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Coronary Vessels; Drug Combinations; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Stents; Ticlopidine	2000
Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2000, Volume: 50, Issue:4 Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Blood Vessel Prosthesis Implantation; Cardiac Catheterization; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Incidence; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Retrospective Studies; Stents; Thrombocytopenia; Thrombolytic Therapy; Ticlopidine	2000
Extensive thrombus prior to elective percutaneous coronary intervention. The Journal of invasive cardiology, 2001, Volume: 13, Issue:7 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Clopidogrel; Coronary Thrombosis; Elective Surgical Procedures; Eptifibatide; Female; Heparin; Humans; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Ticlopidine	2001
Coronary stent thrombosis: insights from the porcine coronary stent model. Thrombosis and haemostasis, 2001, Volume: 86, Issue:3 Topics: Animals; Anticoagulants; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Coronary Vessels; Drug Therapy, Combination; Heparin; Humans; Models, Animal; Myocardial Infarction; Stents; Swine; Ticlopidine	2001
Aspirin plus clopidogrel for everyone: panacea comes true in the 21st century. The Journal of invasive cardiology, 2001, Volume: 13, Issue:12 Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Postoperative Complications; Prosthesis Implantation; Stents; Ticlopidine	2001
Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries. Thrombosis and haemostasis, 2001, Volume: 86, Issue:5 Topics: Animals; Aspirin; Blood Coagulation Tests; Bradykinin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Disease Models, Animal; Dogs; Drug Evaluation; Metabolic Clearance Rate; Peptide Fragments; Platelet Function Tests; Regional Blood Flow; Therapeutic Equivalency; Ticlopidine; Time Factors	2001
[Two platelet inhibitors after acute coronary syndrome. Many colleagues are not aware of this]. MMW Fortschritte der Medizin, 2002, Mar-28, Volume: 144, Issue:13 Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Survival Rate; Ticlopidine	2002